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GENERAL INTRODUCTION 
ADP-Ribosylation reactions 
ADP-ribosylation is a post-translational modification, in which an 
ADP-ribose moiety is transferred from p-NAD+ to specific amino acid 
residues of proteins by various ADP-ribosyltransferases (1). ADP-
ribosylation reactions are classified into two types: poly(ADP-
ribosyl)ation and mono(ADP-ribosyl)ation reactions (1). These two 
types of modification are different with respect to the chain length of 
ADP-ribose units, the chemical nature of ADP-ribosyl protein linkage, 
the enzymes involved, and the sites of reaction (1). 
(I) Poly(ADP-ribosyl)ation: 
Poly-ADPR reaction was first reported by P. Mandel et. al. in 1963. 
Since then, movement towards better understanding the function of 
poly-ADPR has been increasingly made. Poly( ADP-ribose) polymerase 
that catalyses this reaction is primarily associated with the nucleus and 
is dependent on the presence of DNA nicks or double-strand breaks for 
its full enzyme activity (2). It is thought to be present in all eukaryotes 
but not in prokaryotes. The purified poly(ADP-ribose)polymerase 
consists of three domains: the N-terminal DNA binding, automodification 
site, and the C-terminal NAD binding domains (3). 
The amino acid residues that become poly(ADP-ribosyl)ated are 
either glutamate or aspartate and their carboxyl group is esterified 
through the OH-group of C-1 of ADP-ribose (1). The principal 
endogenous substrate in the cultured cells subjected to DNA damage 
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appears to be poly(ADP-ribose)pol>Tnerase itself (1). Based on the 
results of inhibitor studies (3-amino-benzamide) (4), and those of 
cellular mutants with decreased poly(ADP-ribose)polymerase activity 
(5, 6), and antisense poly(ADP-ribose)polymerase RNA (7), poly(ADP-
ribose)polymerase is now believed to play a role in DNA repair and/or 
cell growth functions. It remains to be established exactiy how this 
enzyme participates in these DNA reactions and what significance the 
presence of the poly(ADP-ribose) polymer is. 
(II) Mono(ADP-ribosyl)ation: 
Mono(ADP-ribosyl)ation reactions have been identified in both 
prokaryotes and eukaryotes. Mono(ADP-ribosyl)ation reactions can be 
classified into four subtypes according to the amino acid residues that 
accomodate ADP-ribose,: arginine-, diphthamide-, cysteine-, and 
asparagine-specific enzymatic ADP-ribosylation (1). Mono(ADP-
ribosyl)ation predominates by far (> ten-fold ) over poly-ADPR in 
mammalian cells, particularly in the extranuclear compartments (8), 
suggesting the importance of this type of reaction. 
The linkages between ADP-ribose and the different specific amino 
acid residue acceptors can be distinguished by their sensitivities to 
different chemicals (Table I) (9, 10). For instance, the carboxyHinkage 
(0-glycoside) is extremely sensitive to acid and hydroxylamine (NH2OH). 
The thioglycosidic bond is stable to NH2OH but is labile to mercuric ions. 
By contrast, the (ADP-ribosyl)arginine linkage (N-glycoside) is sensitive 
to NH2OH with a half-life of 30-60 min. Therefore, the possible 
structures can be differentiated. 
Table I: Stability of protein: ADP-ribose linkages 
ADP-ribosyl Formic acid HydrojQ^lamine Hg2+ NaOH 
linkage to: (44%) (lM,pH7.0) (10 mM) (IM) 
Carboxylate Stable Rapid release Stable Released 
Arginine Stable Slow release Stable Released 
Cysteine Stable Stable Released Released 
Dlphthamide Stable Stable Stable Stable 
Asparagine Stable Stable Stable Stable 
Ser/Thr Released Stable Stable Stable 
Lysine Stable Stable Stable Released 
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Prokaryotic mono(ADP-ribosyl)transferases 
The best studied mono(ADP-ribosyl) transferases are the bacterial 
toxins, diphtheria toxin, pseudomona exotoxin A, cholera toxin, E. coli 
heat labile enterotoxin, and pertussis toxin. These may be classified as 
(A-B) subunit ADP-ribosylating toxins (11). In these proteins, the toxic 
enzymatic activity is generally carried by the A subunit, and the B 
subunit possesses the cell-membrane receptor binding activity and aids 
the penetration of the A subunit into host cell cytoplasm (11). 
Target proteins for these transferases have been identified and 
characterized. Diphtheria toxin A subunit ADP-ribosylates a post-
translationally modified histidine residue of elongation factor 2 (EF2), 
called diphthamide. ADP-ribosylation of EF2 inactivates its translocase 
activity, thereby inhibiting protein synthesis (11). Cholera toxin, 
produced by Vibrio cholerae, ADP-ribosylates an arginine residue of 
Gsa (12). ADP-ribosylated Gsa can activate adenylate cyclase but is 
incapable of hydrolyzing OTP (12). Therefore, the adenylate cyclase 
remains locked in its active state. As a consequence, an increase in the 
intracellular cAMP concentrations induced by this modification causes 
the symptoms of cholera. This modification catalyzed by cholera toxin 
requires certain components of the cytosol that are ADP-ribosylation 
factors (ARF) acting as OTP-dependent allosteric activators of cholera 
toxin. Pertussis toxin, produced by Bordetella pertussis, has been 
demonstrated to catalyze the transfer of ADP-ribose to a cysteine 
residue near the carboj^^l terminus of the a-subunit of the inhibitory G-
proteins, Goa or Gia (13). In doing so, it prevents Gia from exchanging its 
5 
bound GDP for GTP and therefore from inhibiting adenylate cyclase and 
causes pertussis (whooping cough). 
Several Clostridium species produce binary toxins consisting of 
component II required for cell entry and component I which possesses 
ADP-ribosyltransferase activity (11). The clostridial ADP-ribosylating 
toxins can be divided into two groups with respect to their protein 
substrates. One group of toxins modifies small GTP-binding proteins of 
the rho family. The other group of transferases belongs to the family of 
actin-ADP-ribosylating toxins. C3 (14, 15) and C3-like (16-18) 
exoenzymes ADP-ribosylate an asparagine residue (Asn-41) (19) of rho 
proteins and cause thereby the disappearance of microfilaments and 
actinomorphic shape changes (20). Thus, the ADP-ribosylation of a rho 
protein seems to be resposible for microfilament disassembly. 
Monomeric actin is the unique substrate for ADP-ribosylation by 
the known toxins of type C2 toxin and several Clostridia enzymes, 
including the iota toxins of C. perfingens type E, C. spiroforme toxin and 
C. difficile, that are distinct from C2 toxin (11). It was shown that the 
acceptor amino acid for ADPR is arginine-177 (21, 22), and it appears 
that all these toxins modify actin at the same site. It was shown that 
actin-ADP-ribosylating toxins disturb the cellular equilibrium between 
F- and G-actin, thereby resulting in the breakdown of the microfilament 
network (23, 24). 
These bacterial toxins described here turn out to be very useful 
tools to study the physiological functions of their eukaryotic target 
proteins, e.g., heterotrimeric G-proteins, actin, and rho proteins etc. One 
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of the most fascinating questions still unanswered is whether the 
targets of toxins are also substrates for AD.P-ribosylation by endogenous 
ADP-ribosyltransferase. 
These bacterial ADP-ribosylating toxins described above are 
involved in disrupting eukaryotic cell metabolism or function. Do 
bacteria use ADP-ribosylation as a mechanism to control their own 
metabolism? Evidence for the ADP-ribosylation of proteins in bacteria 
has been reported. The most thoroghly studied example is the 
reversible ADP-ribosylation of the dinitrogenase reductase from the 
photosynthetic bacterium Rhodospirillum rubrum (25, 26). 
Dinitrogenase reductase is ADP-ribosylated on arginine-101 by 
dinitrogenase reductase ADP-ribosyltransferase (DRAT). ADP-
ribosylation of dinitrogenase reductase occurs in response to fixed 
nitrogen sources such as ammonium or glutamine or in response to 
darkness. ADP-ribosylation causes a complete inactivation of 
dinitrogenase reductase. The enzyme is activated by removal of ADP-
ribose group by dinitrogenase reductase activating glycohydrolase 
(DRAG). More recently, the glutamine synthetase III (GSIII) from 
Rhizobium meliloti was also shown to be a target for ADP-ribosylation 
and modification causes the loss of GSIII biosynthetic activity (27). 
ADP-ribosylation could therefore play many more important roles in 
the endogenous regulation of microbial metabolism. 
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Eukaryotic mono (ADP-ribosyl) transferases 
Mono(ADP-ribosyl) transferase activity has also been detected in a 
variety of cells and tissues, including turkey and human erythrocytes 
(28-31), rat and hen livers (32, 33), rabbit and pig skeletal muscle (34, 
35), chicken heterophils (36), and a variety of murine cell lines, 
including lymphocytes (37). Research into endogenous mono(ADP-
ribosyl) ation in animal cells has also led to the identification of ADP-
ribosyltransferases that are specific not only for arginine, but also for 
cysteine (38) and diphthamide residues (39). 
The physiological role of endogenous mono(ADP-
ribosyl) transferases regarding their substrates and cellular functions is 
still unclear. However, several potential substrates and functions of 
eukaryotic ADP-ribosyltransferases have been suggested. Soluble 
turkey erythrocyte arginine-specific mono (ADP-ribosyl) transferase A 
(40), a 28 kDa single polypeptide activated by salts, has been 
extensively studied. Ovine brain glutamine synthetase, recombinant 
Ha-ras-p21, a and p subunits of transducin, and chicken erythrocyte 
tubulin have been reported to be the substrate proteins for turkey 
erythrocyte transferase A (41). ADP-ribosylation of those proteins 
catalyzed by transferase A results in inhibition of activity, GTPase and 
GTP-binding activities, and microtubule assembly, respectively (41). 
Chicken heterophil arginine-specific ADPRT has a molecular mass 
of 27.5 kDa and is independent of salts for its activity (36). In 
permeabilized heterophils, the 33 kDa and to a less extent 43 kDa 
proteins, corresponding to p33 and cytosolic actin, respectively, were 
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labeled after incubation with [32p]NAD, thereby indicating that these 
two proteins are endogenous targets for chicken transferase (36,42). It 
was shown that the partial amino acid sequence of p33, except for one 
amino acid, matched that of myb-induced myeloid specific protein-1, 
mim-1. The expression of mim-1 is regulated by the nuclear oncogene 
product Myb (43), but the function of mim-l is still not known. ADP-
ribosylation of actin inhibited the polymerization of actin monomers, 
thereby suggesting that ADP-ribosylation of actin catalyzed by 
heterophil transferase may affect the morphology or movement of the 
cells by altering the state of actin polymerization. 
A link between endogenous mono(ADP-ribosyl)ation and 
adenylate cyclase activity has been suggested by several findings. 
Chick spleen cell membrane contains an (ADP-ribosyl) transferase which 
can catalyze the endogenous GTP-dependent ADP-ribosylation of the 
arginine residue of Gsa. and this modification enhances basal adenylyl 
cyclase activity in the membrane (44). In addition, measurement of 
ADP-ribosyltransferase activity in intact human platelets revealed that 
a protein with a similar molecular mass to Gsa is a substrate for 
eukaryotic ADP-ribosyltransferase (45). Recently, additional data about 
canine cardiac sarcolemma has been reported (46), thereby supporting 
the hypothesis that endogenous transferase modifies the arginine 
residue of Gsa> the acceptor site for cholera toxin-catalyzed ADP-
ribosylation, resulting in activation of adenylate cyclase. These findings 
suggest that endogenous ADP-ribosyltransferases may play an 
important role in signal transduction involving G-proteins. 
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Nitric oxide (NO), a novel biological messenger, has been suggested 
to be a regulator of endogenous intracellular ADP-ribosylation. It was 
initially found by Brune and Lapetina that NO-generating agents, added 
to cytosolic extracts from platelets and other mammalian cell types, 
activated a cytosolic enzyme that mono(ADP-ribosyl)ated a cysteinyl 
residue of a specific 39-kDa protein (47,48). The identity of the 39-kDa 
protein has been revealed as glyceraldehyde-3-phosphate 
dehygrogenase (GAPDH) (49, 50). Recently, however, the conclusion 
that ADP-ribosylation of GAPDH by an endogenous ADP-
ribosyltransferase in the presence of NAD+ and NO was ruled out, 
because purified GAPDH incubated with NAD+ and NO was modified 
similarly to that in cell homogenates (49, 50). The hypothesis that 
GAPDH has an ADP-ribosyltransferase activity was later rejected by 
finding that the whole NAD+ molecule is bound to GAPDH, not just the 
ADP-ribose moiety from NAD+ (51). 
Inhibitors of ADP-ribosylation reactions 
One effective approach to investigate the biological functions of 
ADP-ribosylation reactions is to modulate the activity of ADP-
ribosylating enzymes in vivo with a specific inhibitor and analyze 
ensuing changes in cellular functions. Many compounds have been 
shown to inhibit the poly(ADP-ribose)polymerase activity in vitro or in 
vivo. Among them, the most frequently used are 3-aminobenzamide, 
nicotinamide, and thymidine. Although their effects are fairly specific 
on poly(ADP-ribose)polymerase, these inhibitors are accompanied by 
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various in vivo side actions and, therefore, their use has left more or 
less inconclusiveness to the results. For example, 3-amino-benzamide 
was reported to inhibit de novo synthesis of DNA (52). Benzamide and 
its derivatives proved to be potent inhibitors of nicotinamide N-
methyltransferase (53), and, in certain cells, to variably inhibit de novo 
synthesis of DNA (52). Therefore, more specific and potent inhibitors 
must be found and used to define the physiological roles of ADP-
ribosylation reactions in cells. 
As listed in Table II (54), many of the inhibitors newly found are 
highly specific for poly(ADP-ribose)polymerase, whereas some act 
selectively on mono(ADP-ribosyl)transferase or nonspecifically on both 
enzymes. The four strongest inhibitors for poly(ADP-ribose)polymerase 
are 4-amino-l,8-naphthalimide, 6(5H)- and 2-nitro-6(5H)-
phenanthridinones, and 1,5-dihydroxyisoquinoline. The 50% inhibitory 
concentrations, 0.18-0.39 |xM, are about 10-20 orders of magnitude 
lower than that of 3-amino-benzamide (33 |aM). A common structural 
feature among all potent inhibitors, including 1-hydroxyisoquinoline, 
chlorthenoxazin, 3-hydroxybenzamide, and 4-hydroxyquinazoline, in 
addition to the four mentioned above, is the presence of a carbonyl 
group built in a polyaromatic heterocyclic skeleton or a carbamoyl 
group attached to an aromatic ring (54). 
Four natural compounds have been identified to be very 
inhibitory to the arginine-specific mono(ADP-ribosyl) transferase from 
Table II: Comparison of inhibitory potencies of various compounds on mono(ADP-
ribosyl)transferasea & poly(ADP-ribose)polymeraseb 
mADPRTa oADPRTb 
Compound Inhibition % at Inhibition % at 
ICSO fuM) 0.1 mM 1.0 mM ICSO 0.1 mM I.O mM 
4-Amino-1,8-naphthalimide <200 45 >70 0.18 99 >99 
6 (5 H)-phenanthridinone <1000 39 >77 0.30 99 >99 
2 Nitro-6 (5 H )phenanthridinone 83 64 >81 0.35 92 >93 
1,5-Dihydroxy isoquinoline 890 15 52 0.39 99 100 
1 -Hydroxy isoquinoline 1500 15 39 7.0 82 98 
Chlorthenoxazin .#  3 24 8.5 80 98 
4-Hydroxyquinazoline 2600 3 18 9.5 80 92 
3-Hydroxybenzamide 9000 5 10 9.1 81 95 
Benzamide 4500 3 18 22 73 92 
Oleic acid (C18:l, cis -9) 200 7 99 82 53 86 
Palmitoleic acid (CI6:1, cis-9) 200 7 99 95 51 86 
Arachidonic acid (C20:4) 66 70 99 44 67 >67 
Arachidic acid (C20:0) 4.4 100 100 _ 1 >18 
Stearic acid (CI8:) 6.1 99 100 - 5 >20 
Palmitc acid (16:0) 16 100 100 - 24 >28 
Vitamin Ki 1.9 >86 >87 520 - >72 
Novobiocin 280 11 100 2200 
-3* 16 
a: Mono(ADP-ribosyl)transferase was abbreviated as mADPRT and was purified from hen heterophils, 
b: Poly(ADP-ribose)polymerase was abbreviated as pADPRT and was purified from calf thymus. 
#: Not done or not measurable. 
*: Stimulation 
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hen heterophils (Table II). They are vitamin Ki and saturated long 
chain fatty acids (arachidic, steric and palmitic acids). Their IC50 values 
are between 1.9 and 16 nM. Another natural inhibitor, novobicin, is 
also very specific for mono(ADP-ribosyl) transferase by competing with 
NAD+. little has been done with these inhibitors mentioned above to 
elucidate the biological functions of the N-linked mono(ADP-
ribosyl)ation in intact cells. 
Recently, an inhibitor of intracellular arginine-specific ADP-
ribosyltransferase, meta-iodobenzylguanidine (MIBG) has received 
more attention. MIBG is a guanidino analogue of the natural 
neurotransmitter norepinephrine. Radiolabeled [131I]MIBG is clinically 
used as a tumor targeting radiopharmaceutical in the diagnosis and 
treatment of adrenergic tumors (55). MIBG has been demonstrated to 
be a high-affinity substrate for mono(ADP-ribosyl)transferase of 
cholera toxin (Kin=6.5 nM) and turkey erythrocyte membranes (56) as 
well as to effectively compete with intracellular acceptors for 
endogenous enzymes (57). The specificity of MIBG as an inhibitor of 
mono-, but not poly-, ADP-ribosylation was demonstrated by Smets and 
coworkers, who showed that MIBG inhibited N-linked mono(ADP-
ribosyl)ation with an IC50 of 100 nM in turkey erythrocycte membrane 
preparations, but did not inhibit poly(ADP-ribosyl)ation in either 
permeabilized S49 or L1210 leukemia cells (56). Thus, MIBG is both a 
substrate for mono(ADP-ribosyl)transferases and an inhibitor of protein 
ADP-ribosylation. Therefore, MIBG has been extensively used as a tool 
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to study the roles of skeletal muscle ADP-ribosyltransferase in our 
laboratory. 
Arginine-specific mono(ADP-ribosyl) transferase from rabbit 
skeletal muscle 
A membrane-associated arginine-specific mono(ADP-
ribosyl)transferase, using low molecular weight guanidino compounds 
(35) or arginine residues in proteins (58-60) as acceptors of ADP-ribose, 
was detected at relatively high levels in rabbit skeletal muscle and in 
cultured skeletal muscle cells (61). The transferase can be inactivated 
by reducing agents (58,62). The divalent cations Mg2+ and Ca2+ had no 
effect on the ADPRT activity (58). High concentrations of Triton X-100 
as well as deoxycholate above 0.01% were inhibitory (58). The muscle 
transferase is highly specific for NAD whereas NADP and NADH are very 
poor substrates (58). When partially purified transferase from rabbit 
skeletal muscle was used, Km values for NAD and L-arginine methyl 
ester (LAME) as substrates were determined to be 0.56 mM and 1.2 
mM, respectively (63). By contrast, MIBG was determined to be a much 
higher affinity substrate for muscle transferase than LAME with Km of 
0.2 mM (unpublished data). The kinetic mechanism was defined as 
random sequential (63). 
Arginine-specific ADP-ribosyltransferase from rabbit skeletal 
muscle has been purified to homogeneity (62, 64, 65). Analysis of the 
purified transferase by SDS-PAGE revealed the presence of a 38 kDa-
protein (62, 64). The enzyme was also cloned from rabbit skeletal 
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muscle (64). The composite cDNA showed a 981-base-pair open reading 
frame, encoding a polypeptide of 36,134 Da, which is consistent with the 
molecular weight determined by SDS-PAGE (64). No extended sequence 
homology was found between muscle transferase and any of the 
bacterial toxins, the ADPRT from Rhodospirillum rubrum, or poly(ADP-
ribose)polymerase (64). It contained two potential sites for N-linked 
glycosylation (64). The expression of arginine-specific ADPRT appears 
to be tissue specific, because the mRNA of the enzyme was found 
primarily in rabbit skeletal and heart muscle but not in smooth muscle, 
brain, lung, kidney, spleen, or liver (64). 
The deduced amino acid sequence of the transferase showed a 
hydrophilic center region surrounded by a stretch of about 20 very 
hydrophobic amino acids at both amino and carboxyl termini (64). This 
suggests that muscle transferase is a glycosyl-phosphatidylinositol 
(GPI)-anchored membrane protein. GPI-anchored proteins are likely 
located on the exterior of the plasma membrane or, to a lesser extent, 
on the luminal face of intracellular vesicles (66, 67). It has been 
reported that treatment of intact transfected cells with 
phosphatidylinositol-specific phospholipase C from Bacillus 
thuringiensis caused almost complete release of the transferase to the 
medium (68). This finding supports the view that ADPRT is located on 
the surface of muscle cells. However, several studies also reported that 
muscle transferase is located in the sarcoplasmic reticulum (59, 65, 69, 
70), and the catalytic activity of the transferase is oriented towards 
15 
cytoplasm (71). The possibility that muscle ADPRT might exist in 
isoforms remains to be determined. 
Dissertation Organization 
This dissertation follows an alternative format in which there are 
three manuscripts included after the General Introduction. The first 
paper describes that the intermediate filament protein-desmin as a 
substrate for muscle ADP-ribosyltransferase and what ADP-ribosylation 
does to desmin's function in vitro, and has been published in 
Biochemical and Biophysical Research Communications. The second 
paper concerns the identification of protein substrates for arginine-
specific ADP-ribosyltransferase using embryonic chick primary muscle 
cell cultures as a working model. Results of the second paper will be 
submitted to Experimental Cell Research. The third paper describes the 
expression and refolding of muscle ADP-ribosyltransferase in E. coli and 
will be submitted to Protein Engineering. Following the third paper is a 
general summary of entire dissertation and an outiook for further work 
is also discussed. Following the General Summary is the General 
References in which the references cited in the General Introduction 
and the General Summary are listed. 
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ADP-RIBOSYLATION OF THE INTERMEDIATE FILAMENT 
PROTEIN DESMIN AND INHIBITION OF DESMIN ASSEMBLY IN 
VITRO BY MUSCLE ADP-RIBOSYLTRANSFERASE 
A paper published in Biochemical and Biophysical Research 
Comunication, (1993) 197, 570-577 
Hui-Yu Huang, Dnoald J. Graves, Richard M. Robson*, 
and Ted W. Huiatt*! 
Department of Biochemistry and Biophysics, *Muscle Biology Group, 
Molecular Biology Bldg., Iowa State University, Ames, L\ 50011 
iTo whom correspondence should be addressed. Fax: 515-294-0453. 
Abbreviations: 
ADPRT ADP-ribosyltransferase 
ADPR ADP-ribosylation 
IF Intermediate filament 
PKA cAMP-dependent protein kinase 
STI Soybean trypsin inhibitor 
Summary 
Arginine-specific mono(ADP-ribosyl)transferase purified from 
rabbit skeletal muscle catalyzes stoichiometric ADP-ribosylation of the 
intermediate filament protein, desmin. In contrast, cholera toxin 
catalyzes a much lower level of ADP-ribosylation of desmin. 
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Modification results in potent inhibition of desmin's ability to assemble 
into filaments. Phosphorylation of desmin by the catalytic subunit of 
cAMP dependent protein kinase is also inhibited by ADP-ribosylation. 
ADP-ribosylation site(s) are located within the N-terminal head domain 
of desmin. 
Introduction 
ADP-ribosylation (ADPR) is a covalent post-translational 
modification of proteins, which involves the transfer of the ADP-ribose 
moiety from I^-NAD+ to specific amino acid side chains of proteins by 
ADP-ribosyltransferases (ADPRTs) (1, 2). The best understood of the 
mono-ADPRTs are the bacterial toxins. The bacterial enzymes exert 
their toxic effects by regulating a variety of cytoplasmic functions in 
eukaryotic cells, such as protein translation {diphtheria toxin) (3) and 
adenylcyclase activity at the plasma membrane {cholera and pertussis 
toxins) (4, 5). Clostridium toxins recently have been shown able to 
ADP-ribosylate non-muscle actin, skeletal muscle actin and low 
molecular weight G proteins (6). 
Eukaryotic mono-ADPRTs have been identified in many animal 
tissues (7-13), but their physiological function remains poorly 
characterized. An arginine-specific mono-ADPRT has been purified 
from rabbit skeletal muscle in our laboratory (14,15). Recently, we 
have examined the effect of a novel, specific inhibitor of cellular 
arginine-specific mono-ADPRTs, meta-iodobenzylguanidine (MIBG) 
(16,17), on differentiation of cultured embryonic chick skeletal 
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myoblasts (18). We found that MIBG reversibly inhibited both 
proliferation and differentiation of cultured myoblasts. In addition, 
the total arginine-specific mono-ADPRT activity increased with 
differentiation in the myogenic cell cultures, and this increase was also 
blocked by MIBG treatment. Therefore, these findings suggested a 
possible role for this type of enzymatic reaction in myogenesis. 
Intermediate filaments (IFs), which are part of the cytoskeleton 
and the nuclear lamina of most eukaryotic cells (19,20), average 10 nm 
in diameter. The overall structure of IF proteins consists of an a-helical 
central rod domain surrounded by non-helical N-terminal head and C-
terminal tail regions. Recently it has been shown that IFs are much 
more dynamic cellular structures than originally beUeved, and the IF 
proteins are subject to covalent modification by phosphorylation that 
alters their assembly-disassembly properties (19). The head domain, 
characterized by a large number of arginine residues, is highly basic. 
The functional importance of arginine residues has been suggested by 
the inhibition of filament formation following removal of the head 
domain by proteolysis (21) and by modification of arginine residues in 
the head domain of the protein (22, 23). Purified IF proteins undergo 
assembly to form filaments when the ionic strength is increased or pH is 
decreased to 7 (24). The muscle-specific type III IF protein, desmin, 
with a molecular mass of 53 kDa, has been shown to be expressed early 
in myogenesis, and may help align and tie together adjacent myofibrils 
during myofibrillogenesis (25), but the details of desmin's role in this 
process remain to be shown. 
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Because ADPR may play a role in myogenesis and because desmin 
is one of the earliest muscle specific gene products expressed, we 
determined if desmin is a substrate for purified skeletal muscle ADPRT. 
We show that desmin is an excellent substrate for the muscle ADPRT 
and that the resulting covalent modification markedly alters desmin's 
ability to assemble into IPs. 
Materials and Methods 
Purification of proteins - Arginine-specific mono-ADPRT obtained 
from the Con A elution step was purified from rabbit skeletal muscle 
(15). Purified desmin was prepared from turkey gizzard (26). Skeletal 
muscle G-actin was purified as described (27). The catalytic subunit of 
PKA was prepared as described (28). 
ADP-ribosylation - Before desmin was used for experiments, it was 
dialyzed overnight against two changes of 10 mM Tris-HCl, pH 8.5, at 4 
oc and then clarified by centrifugation at 100,000 x g for 30 min. 
Clarified desmin (0.25 mg/ml) was routinely ADP-ribosylated by 
incubation with 20 ^ig/ml muscle ADPRT, 1 mM [32p]NAD, 10 mM Tris-
HCl, pH 8.5, at 30 oc, except as specified in Fig. 1. Soybean trypsin 
inhibitor (STI) (Sigma) and skeletal muscle G-actin at concentrations of 
0.25 mg/ml were used in the indicated experiments. ADPR by cholera 
toxin A subunit was carried out in a reaction mixture containing 200 
mM potassium phosphate, pH 7.0, 20 mM DTT, and 10 ng/ml activated 
cholera toxin A subunit at 30 oc. ADPR reaction was stopped by 
removing unreacted [32p]NAD by spin dialysis with Amicon centricon 
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30. The incorporation of ADP-ribose in proteins was measured by the 
filter paper assay (29). 
Phosphorylation - Control and ADP-ribosylated desmin at 
concentrations of 0.25 mg/ml were phosphorylated by incubation with 
30 ixg/ml catalytic subunit of PKA in 10 mM Hepes buffer, pH 7.5, 0.3 
mM MgCl2, 0.5 mM DTT, and 1 mM [y-32p]aTP at 30 oC. 
Electron microscopy - Electron microscope observations were made 
on negatively stained samples as described (26) and examined in a JEOL 
100 CX-II electron microscope operated at 80 kV. 
IF Assembly- Control and ADP-ribosylated desmin were dialyzed 
against assembly buffer containing 10 mM Tris-HCl, pH 7.5, 170 mM 
NaCl, 5 mM DTT, and 0.2 mM MgCl2 at 4 oC for 20 hr to promote 
filament formation (24, 26). 
Protein concentration - Protein concentration was determined by 
using Pierce BCA protein assay reagent. 
Domain assignment of ADP-ribosylated desmin - ADP-ribosylated 
desmin was digested with lysyl endopeptidase according to the 
conditions described by Kusubata et al. (30). Ten ^ig of the digest and of 
ADP-ribosylated desmin were subjected to 15 % SDS-PAGE followed by 
Coomassie blue staining and autoradiography. 
Results and Discussion 
Muscle specific desmin was treated with arginine-specific mono-
ADPRT under conditions selected to inhibit or promote IF assembly. As 
shown in Fig. 1, we found that muscle ADPRT catalyzed the ADPR of 
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about 2-2.5 mol of arginine residues per mol of 53 kDa-subunit of 
soluble desmin in 10 mM Tris-HCl, pH 8.5, after 4-h incubation. Less 
incorporation of ADP-ribose was obtained when desmin was incubated 
with ADPRT under conditions selected to partly promote assembly of 
desmin into 10-nm filaments (low ionic strength at pH 7.5), and much 
less under conditions that favor additional assembly (pH 8.5 with 150 
mM NaCl). 
We also tested whether desmin can serve as good a substrate for a 
different transferase, namely cholera toxin. Unlike the significant level 
of ADP-ribose incorporation catalyzed by muscle ADPRT, cholera toxin 
catalyzed a very low stoichiometry of less than 0.06 mol ADP-ribose per 
mol desmin as shown in the Table I. To further address whether the 
difference in ADP-ribosylation of desmin catalyzed by these two 
enzymes is due to their different substrate specificity, STI which 
contains the potential arginine residues targeted for deimination (31), 
was tested. As shown in Table I, STI was a very good substrate for 
cholera toxin, but it was a poor substrate for muscle ADPRT. ADPR of 
skeletal muscle G-actin by Clostridium perfringens iota toxin has been 
reported, and the modification caused inhibition of actin polymerization 
(32, 33). We examined the possibility of skeletal muscle G-actin being 
a target substrate for muscle ADPRT. A very low extent of ADPR (i.e., 
0.06 mol ADP-ribose/mol G-actin) was observed (Table I). That muscle 
ADPRT and bacterial toxins showed different substrate specificity is not 
unexpected because no sequence homology has been found between 
rabbit skeletal muscle ADPRT and bacterial toxins (34). 
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To examine wliat ADPR does to a physiological-like function of 
desmin, the effect of ADPR on the assembly of desmin was investigated 
by using both a sedimentation assay and electron microscopy. Fig. 2 
shows that the amoimt of soluble desmin remaining in the supernatant 
increased as the extent of ADPR increased. Electron microscopy (Fig. 3) 
demonstrated that ADPR inhibited assembly of desmin into filaments. 
Control desmin, with no ADP-ribose incorporation (Fig. 3A), assembled 
into 10-nm diameter filaments after dialysis against assembly buffer. 
After ADPR, desmin did not form typical 10 nm filaments (Fig. SB, 3C), 
and these samples consisted primarily of assembly intermediates, along 
with a few short filaments and some non-filamentous aggregates. The 
number of short filaments and aggregates decreased further with 
increasing ADP-ribose incorporation. These results indicated that ADPR 
of desmin by muscle ADPRT caused a marked inhibition of desmin's 
ability to self assemble. 
It has been shown that ADPR of arginyl residues near 
phosphorylation sites inhibited phosphorylation by PKA (35-37). 
Because ADPR is a reversible reaction, it has been suggested that ADPR 
cou ld  regu la te  spec i f i c  phosphory la t ion  reac t ions  (3  6 ,38) .  
Phosphorylation of desmin by PKA and protein kinase C occurs in the N-
terminal head domain and inhibits filament assembly (39, 40). The 
phosphorylation competence of ADP-ribosylated and control desmin 
was analyzed. As shown in Fig. 4, phosphorylation of soluble desmin by 
the catalytic subunit of PKA was significantly inhibited by previous 
ADPR. When desmin with 1.3 mol ADP-ribose per mol 53-kDa protein 
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was used for phosphorylation, about 75% inhibition was observed. This 
result also suggested that the head domain is the target for both ADPRT 
and PKA. This result lends support to the view that ADPR may be a 
mechanism modulating phosphorylation. To locate the ADPR site(s), 
[32p]NAD labeled desmin with 1.2 mol of ADP-ribose per mol of 53-kDa 
desmin was cleaved with a lysine-specific protease and analyzed by 
SDS-PAGE followed by autoradiography. The head domain of desmin 
contains no lysine residues; thus, digestion with lysyl endopeptidase 
produces a small fragment of about 12-14 kDa, which includes and 
consists mainly of the intact head domain (30). As shown in Fig. 5, 
virtually all of the radioactivity associated with the ADP-ribosylated 
desmin was found in the small fragment migrating to a position 
corresponding to about 12-14 kDa. This result confirmed that the ADPR 
site(s) were located in the head domain. Work is in progress in our 
laboratory to define the sequence of the modified site(s). 
In summary, we have shown that the muscle-specific IF protein, 
desmin, is covalentiy modified by muscle arginine-specific mono-ADPRT 
in vitro. ADPR takes place within the head domain of desmin and 
results in inhibition of desmin self-assembly. ADPR of desmin by 
muscle ADPRT causes subsequent inhibition of phosphorylation by the 
catalytic subunit of PKA.. These findings, coupled with the observations 
that (a) ADP-ribosylarginine hydrolase that catalyzes the reverse 
reaction of ADPR has been identified in many animal tissues, including 
skeletal muscle (41), (b) skeletal muscle ADPRT is a glycosyl-
phosphatidylinositol-linked membrane protein (15, 34), and (c) desmin 
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interacts with, or is anchored, via its N-terminal head domain to 
ankyrin at the plasma membrane (42), suggest that ADPR might play an 
important role in regulating desmin filaments and functions. 
Acknowledgments 
This research was supported in part by grants from the National 
Institutes of Health (GM-34262), Muscular Dystrophy Association, 
American Heart Association, Iowa Affiliate, and USDA Competitive 
Grants Program Award 92-37206-8051. This is Journal Paper J-15581 
of the Iowa Agriculture and Home Economics Experiment Station, Ames, 
lA, Projects 2677, 2921, 3169, and 2127. 
References 
1. Mandel, P., Okazaki, H., and Neidergang, C. (1982) Prog. Nucleic 
Acids Res. Mol. Biol. 27.1-51. 
2. Ueda, K., and Hayaishi, 0. (1985) Annu. Rev. Biochem. 54.73-
100. 
3. Robinson, E. A., Hendrickson, D., and Maxwell, E. S. (1974) L 
Biol. Chem. 249. 5088-5093. 
4. Oilman, A. G. (1984) T. Clin. Invest. 73. 1-4. 
5. Van Dop, C., Tsubokawa, M., Bouren, H. R., and Ramachandran, J. 
(1984) T. Biol. Chem. 259. 696-698. 
6. Kato. I. (1991) Microbiol. Immunol. 35. 349-359. 
7. Beckner, S. K., and Blecher, M. (1981) Biochim. Bioohvs. Acta. 
673. 477-486. 
25 
8. Moss, J., and Vaughan, M. (1978) Proc. Nad. Acad. Sci. USA 75. 
3621-3624. 
9. Iglewski, W. J., Lee, H., and MuUer, P. (1984) FEES Lett. 173. 
113-118. 
10. Tanigawa, Y., Tsuchiya, M., Imai, Y., and Shimoyama, M. (1984) 
T. BioL Chem. 259. 2022-2029. 
11. Godeau, F., Belin, D., and Koide, S. S. (1984) Anal. Biochem. 137. 
287-296. 
12. Vitti, P., Wolf, M. J. S., Acquaviva, A. M., Epstein, M., and Kohn, 
L. D. (1982) Proc. Natl. Acad. Sci. USA 79. 1525-1529. 
13. Soman, G., Mickelson, J. R., Louis, C. F., and Graves, D. J. (1984) 
Biochem. Biophvs. Res. Commun. 120. 973-980. 
14. Soman, G., and Graves, D. J. (1988) Arch. Biochem. Biophvs. 260. 
56-66. 
15. Peterson, J. E., Larew, J. S.-A., and Graves, D. J. (1990) T. Biol. 
Chem. 265. 17062-17069. 
16. Loesberg, C., Van Rooij, H., and Smets, L. A. (1990) Biochim. 
Biophvs. Acta 1037. 92-97. 
17. Smets, L A., Loesberg, C., Janssen, M., and Van Rooij, H. (1990) 
Biochim. Biophvs. Acta 1054, 49-55. 
18. Shanta, V. K., Huiatt, T. W., Huang, H. Y., Peterson, J. E., and 
Graves, D. J. (1992) Expl. cell Res. 201. 33-42. 
19. Robson, R. M. (1989) Curr. Qpin. Cell Biol. 1. 36-43. 
20. Van de Klundert, F. A. J. M., Raats, J. M. H., and Bloemendal, H. 
(1993) Eur. T. Biochem. 214. 351-366. 
26 
21. Perides, G., Kuhn, S., Scherbarth, A., and Traub, P. (1987) Eur. T. 
Cell Biol. 43. 450-458. 
22. Traub, P., and Vorgias, C. E. (1984) T. Cell Sci 65.1-20. 
23. Inagald, M., Takahara, H., Nish, Y., Sugawara, K., and Sato, C. 
(1988^ T. Biol. Chem. 264. 18119-18125. 
24. Ip, W., Hartzer, M. K., Pang, Y.-Y.S., and Robson, R. M. (1985) J. 
Mol. Biol. 183. 365-375. 
25. Lazarides, E. (1982) Annu. Rev. Biochem. 51. 219-250. 
26. Huiatt, T. W., Robson, R. M., Arakawa, N., and Stromer, M. H. 
(1980) T. Biol. Chem. 255. 6981-6989. 
27. Evans, R. R., Robson, R. M., and Sromer, M. H. (1984) T. Biol. 
Chem. 259. 3916-3924. 
28. Peters, K. A., Demaille, J. G., and Fisher, E. H. (1977) 
Biochemistrv 26. 5691-5697. 
29. Reimann, E. M., Walsh, D. A., and Krebs, E. G. (1971) T. Biol. 
Chem. 246. 1986-1995. 
30. Kusubata, M., Matsuoka, Y., Tsujimura, K., Ito, H., Ando, S., 
Kamijo, M., Yasuda, H., Ohba, Y., Okumura, E., Kishimoto, T., and 
Inagaki, M. (1993) Biochem. Bioohvs. Res Commim. 190. 927-
934. 
31. Takahara, H., Okamoto, H., and Sugawara, K. (1985) T. Biol. 
Chem. 260. 8378-8383. 
32. Schering, B., Barmann, M., Chhatwal, G. S., Geipel, U., and 
Aktories, K. (1988) Eur. T. Biochem. 171. 225-229. 
27 
33. Vandekerckhove, J., Schering, B., Barmann, M., and Aktories, K. 
(1988) T. Biol. Chem. 263. 696-700. 
34. Zolkiewska, A., Nightingale, M. S., and Moss, J. (1992) Proc. Natl. 
Acad. Sci. USA 89. 11352-11356. 
35. Tanigawa, Y., Tsuchiya, M., Imai, Y., and Shimoyama, M. (1984) 
T. Biol. Chem. 259. 2022-2029. 
36. Tsuchiya, M., Tanigawa, Y., Ushiroyama, T., Matsuura, R., and 
Shimoyama, M. (1985) Eur. T. Biochem. 147. 33-40. 
37. Jesser, M., Hog, F., Chypre, C., Leterrier, J.-F., and Mandel, P. 
(1993) Biochem. Biophvs. Res. Commun. 194. 916-922. 
38. Kharadia, S., and Graves, D. J. (1987) T. Biol. Chem. 262.17379-
17383. 
39. Geisler, N., and Weber, K. (1988) EMBO T. 7.15-20. 
40. Inagaki, M., Gonda, Y., Matsuyama, M., Nishizawa, K., Nishi, Y., 
and Sato, C. (1988) T. Biol. Chem. 263, 5970-5978. 
41. Chang, Y. -C., Soman, G., and Graves, D. J. (1986) Biochem. 
Biophvs. Res. Commun. 139. 932-939. 
42. Georgatos, S. D., Weber, K., Geisler, N., Blobel, G. (1987) Proc. 
Natl. Acad. Sci. USA 84. 6780-6784. 
28 
Table I 
ADP-ribosylation by muscle transferase 
and cholera toxin A subunit 
ADP-ribosylationi 
Protein Muscle Cholera toxin 
transferase A subunit 
Desmin 2-2.5 <0.06 
STI 0.23 1-2 
G-actin 0.06 ND 
iData are expressed as mole ADP-ribose per 
mol protein 
ND: Not determined 
Figure 1. Time course of ADPR of desmin by muscle ADPRT. 
Purified desmin (0.25 mg/ml was ADP-ribosylated by 
incubation in 10 mM Tris-HCl, pH 8.5 (•), or 10 mM 
Tris-HCl, pH 7.5 (•), or 10 mM Tris-HCl, pH 8.5,150 mM 
NaCl (A), with [32p]NAD and muscle ADPRT at 30 oc. 
30 
2.5 
pH 8.5 
2 -
1.5-
pH 7.5 
0.5-
pH 8.5 + 150 mM NaCl 
0 1 2 3 4 
Time (hours) 
Figure 2. The percentage of desmin remaining unassembled after 
ADPR. Control (reaction mixture stopped at time 0 min 
with no incorporation) and ADP-ribosylated desmin 
with different levels of incorporation (0.82,1.2, and 1.6 
mol ADP-ribose/mol desmin) were induced to form 
filaments under assembly conditions. The amounts of 
desmin recovered in the supernatant were measure 
after sedimentation at 100,000 x g for 30 min. 
Percentage of desmin recovered 
in the supernatant (%) 
Figure 3. Electron microscopy of the negatively stained control 
(A) and ADP-ribosylated (B, C) desmin after incubation 
under filament-forming conditions (samples selected 
from Fig. 2 before sedimentation). The samples were 
taken at (A) 0 min (no incorporation), (B) 90 min (0.82 
mol/mol), and (C) 240 min (1.6 mol/mol) after ADPR. 
Bar=0.25 nm. 

Figure 4. Time course of phosphorylation by the catalytic subunit 
of PKA of control (•) and ADP-ribosylated desmin (1.3 
mol ADP-ribose/mol desmin) (•). 
Extent of phosphorylation 
(mol Pi/mol desmin) 
O O O O  
O h O A O ^ b o M M A C ^ b o N )  
Figure 5. Identification of ADP-ribosylated desmin domain. 
Labeled proteins before and after lysyl endopeptidase 
treatment, were analyzed by SDS-PAGE. (A) the gel 
patterns and (B) the corresponding autoradiogram. 
Lane 1, ADP-ribosylated desmin; lane 2, ADP-
ribosylated desmin after cleavage with lysyl 
endopeptidase. Lane 3, molecular mass markers of 
97.4, 66.2, 42.7, 31, 21.5, and 14.4 kDa. 
(A) (B) 
1 2  3  1  2  
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Abstract 
In previous studies, we have shown that a specific inhibitor of 
cellular arginine-specific mono(ADP-ribosyl)transferase, meta-
iodobenzylguanidine (MIBG), reversibly inhibited both proliferation and 
differentiation of cultured embryonic chick primary muscle myoblasts. 
In addition, we observed that arginine-specific ADP-ribosyltransferase 
activity increased with muscle cell differentiation in cultures. This 
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increase in transferase activity suggests an important role for the 
enzyme in the myotubes. Therefore, muscle cell cultures, especially the 
96-h myotube cultures which contain the highest levels of ADP-
ribosyltransferase, were used as a working system to determine the 
cellular protein substrates for arginine-specific ADP-ribosyltransferase. 
When membrane fractions extracted from 96-h chick myotubes 
were incubated with [32p]NAD at 30 for 30 min, only a few proteins 
were labeled under conditions favorable for mono(ADP-ribosyl)ation to 
occur. The labeling of two proteins of 36 k and 56 kDa was blocked in 
the presence of arginine-specific mono(ADP-ribosyl)transferase 
inhibitors, MIBG and novobiocin. To prove that these proteins are 
indeed the targets for arginine-specific mono(ADP-ribosyl)ation, active 
recombinant muscle ADP-ribosyltransferase was incubated with 
membrane proteins under the same conditions. ADP-ribosylation of 
these two membrane proteins, as seen in the endogenous reactions, was 
also catalyzed by the added muscle transferase. ADP-ribosylation of 
these two proteins was greatiy enhanced in the presence of exogenous 
muscle transferase as compared to endogenous ADP-ribosylation, and 
also inhibited by inhibitors. Effects of MIBG and novobiocin on protein 
labeling suggested that 56 k and 36 kDa proteins are the endogenous 
target substrates for muscle transferase. Immunoblot analysis 
demonstrated that the 56 kDa protein reacted with antibody specific for 
desmin, indicating that desmin might be an in vivo target for muscle 
transferase. 
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Introduction 
ADP-ribosylation is a covalent post-translational modification of 
proteins, which involves the transfer of the ADP-ribose moiety from p-
NAD+ to proteins by specific ADP-ribosyltransferases (1). In eukaryotic 
cells, two classes of ADP-ribosylation reaction can be distinguished, 
namely, mono and poly(ADP-ribosyl)ation (1). These two types of 
modification differ not only in the length of ADP-ribose chain, but also 
with respect to the chemical nature of ADP-ribosyl protein bond, the 
enzymes involved, and the site of reaction. Poly(ADP-
ribose)polymerase is a nuclear protein and is suggested to be involved 
in DNA repair. On the other hand, mono(ADP-ribosyl)transferases are 
found mainly in the cytoplasm and cell membranes. 
Endogenous mono(ADP-ribosyl) transferases specific for ADP-
ribosylation of arginine, cysteine, and diphthamide residues have been 
identified in many tissues of different animal species (2-11). Among 
them, arginine-specific ADP-ribosyltransferases are the best 
characterized transferases. This type of transferase includes four 
distinct transferases purified from cytosol, membrane fraction, and 
nucleus of turkey erythrocytes (12, 4, 5), and a transferase from 
skeletal muscle (9, 13). An arginine-specific mono-ADPRT transferase 
was purified to > 95% homogeneity from rabbit skeletal muscle 
microsomes by a combination of DE-52 cellulose, concanavalin A 
agarose, 3-aminobenzamide-agarose, and size-exclusion HPLC in our 
laboratory (14). Two different molecular masses of the enzyme, 39,000 
± 500 (a form) and 38,500 ± 500 (p form), were isolated indicating that 
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isoforms of the muscle transferase might be present in different 
comparments (14). In contrast to the cholera toxin A subunit, which 
requires reduction for its activity, the muscle transferase was found to 
be inactivated by reducing agents (14), thereby suggesting 
intramolecular disulfide(s) are required for its full activity. Alternative 
methods of purification of the rabbit skeletal muscle ADP-
ribosyltransferase have also been reported (15, 16). This enzyme was 
also recendy cloned and shown to be a glycosylphosphatidylinositol 
(GPI)-anchored membrane protein in rabbit skeletal muscle cells (15). 
It has been suggested that ADP-ribosyltransferase plays a role in 
signal transduction involving G-proteins. ADP-ribosylations of Gsa 
catalyzed by a transferase from chicken spleen membrane (17), human 
platelet (18), and canine cardiac sarcolemma (19), resulting in 
inactivation of adenylate cyclase activity, have been reported. Also, 
Ca2+-ATPase in the sarcoplasmic reticulum (SR) was shown to be ADP-
ribosylated (20). Modification of Ca2+-ATPase inhibited the ATP 
hydrolyzing activity implicating a role in the regulation of Ca2+ 
transport in the SR (21). Recentiy, skeletal muscle integrin a7 has been 
shown to be ADP-ribosylated when intact mouse muscle C2C12 cells 
were incubated with extracellular [32p]NAD (22). 
Recent data collected from our laboratory demonstrated that 
meta-iodobenzylguanidine (MIBG), both a substrate for arginine-specific 
mono(ADP-ribosyl) transferase and a competetive inhibitor of cellular 
protein ADP-ribosylation, reversibly inhibited both proliferation and 
differentiation of cultured embryonic chick skeletal myoblasts (23). 
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The conclusions were based on the effects of MIBG on cell fusion, 
creatine kinase activity, and protein and DNA contents. Arginine-
specific ADP-ribosyltransferase was found to be predominately 
associated with the cell membrane, and its activity increased with 
differentiation in the primary myogenic cell cultures. A similar finding 
was also reported for mouse skeletal muscle C2C12 cells (22). The 
increase in transferase activity suggests to us an important role for the 
enzyme in the myotubes. But, it is not certain what substrate proteins 
can be modified in the muscle cell by ADP-ribosylation. Therefore, 
embryonic chick primary muscle cell cultures, especially the 96-h 
myotube cultures which contain the highest levels of ADP-
ribosyltransferase, were used as a working system to determine the 
cellular protein substrates for arginine-specific ADP-ribosyltransferase. 
Materials and Methods 
Cell cultures - Myogenic cells were isolated from leg and thigh muscle 
of 12-day chick embryos according to the procedure of Ridpath et al. 
(24). Cultures were plated on collagen-coated Falcon tissue culture 
dishes at a density of about 2 X 10^ cells per ml and a volume of 3 ml 
on 60-mm or 15 ml on 150-mm plates. Cells were maintainted by daily 
feeding with medium consisting of 86.5% (v/v) Dulbecco's MEM 
supplemented with nonessential amino acids, 10% horse serum, 2.5% 
chick embryo extract, 50 lU penicillin/100 ml, and 1% Fungizone and 
incubated at 37 oc in an atmosphere of 5% CO2 and 95% air. 
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Proteins - Active muscle arginine-specific mono(ADP-
ribosyl) transferase was expressed and renatured according to the 
procedure described in Section III. ADP-ribosylarginine hydrolase was 
partially purified from rat brains (25). The protein concentrations were 
determined by the Bradford assay (26) using commercially prepared 
reagent from Bio-Rad. 
Subcellular fractionation - 96-h culture dishes were rinsed three 
times with PBS and cells were scraped off with a rubber policeman with 
PBS. Cells were collected by low-speed centrifugation (800 g, 5 min) 
and resuspended in hypotonic buffer (10 mM Tris, 0.2 mM MgClz, pH 
7.4) (27). After a 10-15 min incubation on ice, cells were disrupted by 
25-30 strokes in a Bounce homogenizer. The homogenates were 
adjusted to a final concentration of 0.25 M sucrose and 1 mM EDTA and 
centrifuged at 1,000 g for 10 min at 4 oc. The supernatant was 
removed immediately and saved. The pellet was resuspended in 0.25 
M sucrose, 1 mM EDTA, 10 mM tris, pH 7.4, 0.2 mM MgClz by five 
strokes in a Bounce homogenizer. This suspension was spun at 1,000 g 
for 10 min, after which the supernatant was removed and combined 
with the supernatant from the first 1,000 g spin. The pooled 1,000-g 
supernatants were centrifuged at 100,000 g for 1.5 h at 4 oC in a 
Beckman Ti 70.1 rotor. The resulting pellet (membrane fractions or 
PlOO) was resuspended in buffer L (50 mM HEPES, pH 7.5, 0.5 mM 
MgCl2, 137 mM NaCl, 1 mM PMSF, 2ng/ml each of aprotinin, leupeptin, 
pepstatin, and E-64), containing 0.25% Nonidet P-40 and assayed 
immediately. 
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ADP-ribosylation of intact embryonic chick muscle cells-96-h 
myotube cells attached to 150-mm plates were rinsed once with PBS 
and twice with buffer L. Ten ml of buffer L containing 20 mM isoniazid, 
10 mM thymidine, and 5 ^M [32p]NAD was added to culture dishes. The 
reaction was carried out at 37 oc for 2 h and stopped by washing the 
culture dishes three times with PBS. Various cellular fractions were 
then prepared as described previously. Proteins were separated on a 
10% SDS-PAGE under reducing conditions, followed by autoradiography. 
ADP-ribosylation of embryonic chick muscle cell membrane 
proteins - Membrane fractions extracted as described above at 
concentrations of 1 mg/ml were preincubated with buffer L containing 
20 mM isoniazid, and 10 mM thymidine at 30 for 5 min. Different 
ligands, including inhibitors and active recombinant muscle ADP-
ribosyltransferase used as indicated, were also preincubated in the 
reaction mixture as described above. ADP-ribosylation was initiated by 
the addition of [32p]NAD (final concentration of 5 m,M with specific 
activity of 25 |xCi) and was allowed to proceed at 37 for 30 min. 
After incubation, the reaction was terminated by adding equal volume 
of 10% TCA. The TCA precipitates were washed once with 10% TCA and 
twice with water saturated ether and resuspended in SDS loading 
buffer. Proteins were analyzed by elctrophoresis on 8% polyacrylamide 
SDS gels under either non-reducing or reducing conditions and 
autoradiography. 
Identification of the ADP-ribosylarginine linkage - Hydrolysis of 
the ADP-ribosylarginine linkage was analyzed by incubation of 100 ^ig 
46 
of prelabeled membrane proteins with partially purified ADP-
ribosylarginine hydrolase from rat brain in a total volume of 200 nl 
containing 20 mM potassium phosphate, pH 7.5, 10 mM DTT, and 15 
mM MgCl2 at 30 oc. The reaction was terminated by adding equal 
volume of 10 % TCA. TCA precipitated protein pellets were then 
washed and analyzed as described previously. 
Immunoblotting - Prelabeled membrane proteins were separated on 
an 8% SDS-polyacrylamide minigel. The gel was equlibrated in 25 mM 
Tris, 200 mM glycine, pH 8.8, for 15 min, and the proteins were 
transferred to Zeta-probe nylon membrane (Bio-Rad) at 60V on ice for 
2h. The membrane was blocked with 1% blotto in TBS (100 mM Tris-
HCl, pH 8.0, 150 mM NaCl) , reacted with rabbit polyclonal antibody 
specific for desmin or muscle ADP-ribosyltransferase, followed by 
alkaline phosphatase conjugated goat anti-rabbit immunoglobulin 
(Sigma). Immunoreactive proteins were visualized with nitroblue 
tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) in 
100 mM Tris-HCl, pH 9.5,100 mM NaCl, and 5 mM MgClz. 
Results and Discussion 
Initially, we labeled the membrane proteins extracted from chick 
myotube cultures or intact cells with 1 mM [32p]NAD in a neutral buffer 
at 30 oc for two hours, and we found that many proteins ranging from 
20 k to 230 k were labeled. However, in doing so, the labeling results 
were not very consistent from time to time. To eliminate the possibility 
of non-specific reactions and NAD+ degradation, a modified method in 
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which thymidine, isoniazid were included in the reaction mixture was 
used (28). Thymidine and isoniazid are the inhibitors of poly(ADP-
ribose)polymerase and NAD glycohydrolase, respectively. We found 
that when membrane fractions extracted from 96-h myotubes were 
incubated with 5 jiM [32p]NAD imder conditions described in "Methods", 
only a few proteins were labeled (Fig. lA). An inhibitor of arginine-
specific mono(ADP-ribosyl)ation, novobiocin, was used to identify the 
substrate proteins that were endogenously ADP-ribosylated. As shown 
in Fig. lA, labeling of proteins with molecular masses of 56 kDa and 36 
kDa, but not 127 kDa, were inhibited in the presence of 1 mM 
novobiocin. In a parallel experiment, ADP-ribosylation of membrane 
proteins by the active recombinant muscle ADP-ribosyltransferase was 
done under the same conditions. We found that the same two proteins, 
56 k and 36 kDa, as seen in endogenous ADP-ribosylation, were the only 
targets to be labeled by active recombinant muscle transferase (Fig. IB). 
The radioactivity associated with these two proteins were greatly 
enhanced (24h exposure in Fig. lA vs. 30 min exposure in IB). Again, 
novobiocin blocked the labeling of these two proteins. These results 
from the inhibitor study on both endogenous and exogenous ADP-
ribosylation of cell membrane proteins provided evidence that the 
modification was arginine-specifc mono(ADP-ribosyl)ation. 
Another class of arginine-specific mono (ADP-ribosyl) transferase 
inhibitor was also used as a tool to identify protein substrates. As 
expected (Fig 2, lane 1), MIBG blocked the labelings of 56 k and 36 kDa 
proteins. The results from the inhibitor study (lane 1 and 3) indicated 
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that novobiocin was a more potent inhibitor than MIBG was. Since 
endogenous ADP-ribosylation of Gsa in the presence of GTPyS or AIF4" 
has been shown to occur in highly purified canine cadiac sarcolemma 
(28), we tested whether one of the proteins identified in our system 
could be Gsa. Unexpectedly, we found that 100 (xM GTPyS inhibited the 
labelings of 56 kDa protein with the inhibition percentage of 61%, and to 
a lesser extent 36 kDa protein (33%), (Fig. 2, lane 4). However, AIF4" 
had no effect on labeling of either protein (data not shown). 
We also examined the effect of ATP on [3 2p]ADP-ribosylation of 
membrane proteins. Interestingly, unlike GTPyS, ATP exerted a 
dramatic inhibitory effect on ADP-ribosylation of only the 56 kDa 
protein (about 91% inhibition), but did not inhibit labeling of the 36 kDa 
protein (Fig. 2, lane 5). This different effect of GTPyS and ATP on the 
endogenous 2 p]ADP-ribosylation of these two proteins suggested that 
56 k and 36 kDa proteins are probably two distinct polypeptides and 
not the reduced fragments of one single polypeptide. The latter view 
was proven to be true because no changes on the mobility of the labeled 
proteins were observed when electrophoresis was performed under 
non-reducing condition (Fig. 3). The inhibition of [32p]iabeling of the 56 
kDa protein by ATP also implied that endogenous phosphorylation of 
this particular protein might have occurred, thereby inhibiting 
subsequent ADP-ribosylation. 
Muscle ADP-ribosyltransferase can be inactivated by reducing 
agents (14). Therefore, the effect of DTT on the labeling of muscle 
membrane proteins was investigated. We found that the radioactivities 
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associated with 56 k and 36 kDa proteins, but not 127 kDa protein, were 
reduced in the presence of 10 mM DTT (Fig. 2, lane 6). This result 
further demonstrated that the modification of these two proteins was 
catalyzed by arginine-specific mono(ADP-ribosyl)transferase in 
myogenic cell cultures. 
To conclusively demonstrate that the modification of the 56 k and 
36 kDa proteins is really arginine-specific mono(ADP-ribosyl)ation 
reaction, chemical stability or hydrolysis by ADP-ribosylarginine 
hydrolase of the ADP-ribosyl protein linkage was investigated. As 
shown in Fig. 4, when prelabeled membrane proteins catalyzed by 
active recombinant muscle transferase were incubated with partially 
purified ADP-ribosylarginine hydrolase from rat brain, the radioactivity 
associated with 56 and 36 kDa proteins declined as incubation time 
increased. 
Our previous studies showed that the muscle specific intermediate 
filament protein, desmin (53 kDa/subunit)), was an excellent in vitro 
substrate for purified muscle arginine-specific mono(ADP-
ribosyl) transferase and that ADP-ribosylation of desmin caused a 
marked inhibition of desmin self-assembly (29). Additionally, ADP-
ribosylation inhibited phosphorylation of desmin by cAMP-dependent 
protein kinase (29). It is known that phosphorylation of desmin also 
alters its assembly-disassembly properties (30). Since the 56 kDa 
protein identified here could be endogenously phosphorylated and has a 
molecular mass similar to that of desmin, immunoblot analysis was 
conducted to test if 56 kDa protein is desmin. As shown in Fig 5., we 
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found that 56 kDa protein that was both endogenously (lane 1 and 2) 
and exogenously (lane 3) ADP-ribosylated was recognized by rabbit 
antiserum specific for desmin. This result strongly suggests that desmin 
might be an in vivo target for muscle ADP-ribosyltransferase. 
The 36 kDa protein might be ADP-ribosyltransferase. Because of 
the similarity of molecular mass between 36 kDa protein and muscle 
transferase (38 kDa), and the fact that ADP-ribosyltransferase can auto-
ADP-ribosylate itself (14), this possibility is suggested. Work is in 
progress to show whether the 36 kDa band can act to ADP-ribosylate 
another substrate, e.g. MIBG. A gel assay developed by Peterson et. al. 
was used earlier to show that the 38 kDa protein prepared from rabbit 
skeletal muscle was arginine-specific mono(ADP-ribosyl) transferase 
(14). 
Recently, skeletal muscle integrin al has been identified as an 
endogenous substrate for muscle ADP-ribosyltransferase when intact 
mouse C2C12 muscle cells were incubated with extracellular [32p]NAD at 
37 oc for 2h (22). The difference between our system and theirs was 
that we utilized the extracted membrane fractions from cultured 
embryonic chick primary muscle cells instead of intact mouse C2C12 
muscle cells. Skeletal muscle integrin a7 is a membrane protein and 
consists of N-terminal large extracellular, transmembrane, and C-
terminal cytoplasmic domains. It has been shown that a monoclonal 
antibody 05, specific for the 35 kDa proteolytic fragment, recognizes 
bands at 120 k and 70 kDa in the non-reducing L8E63 myotube lysate 
and at 35 k and 100 kDa upon reduction (31). With our working 
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system, we did not find that a protein with the molecular mass similar 
to integrin a7 was predominately labeled. Also, no changes on gel 
mobility of the labeled proteins were observed under either non-
reducing or reducing conditions (Fig. 3) ruling out the possibility that 
these two proteins identified here were fragments of integrin a7. 
Labeling of intact chick primary myotube cultures with 
extracellular [32p]NAD under the same conditions used in this study 
showed that proteins derived from nuclear pellet, cytosolic, and 
membrane fractions ranging from 14 k to 200 kDa were labeled (Fig. 6, 
lane 1-2: nuclear pellet, lane 3-4: cytosolic fractions, and lane 5-6: 
membrane fractions). The labeling of these proteins was almost 
completely inhibited in the presence of 2 mM novobiocin (lane 2, 4, and 
6). P-NAD+ is supposedly not able to cross the cell membrane due to its 
highly hydrophilic property and no known receptors on the cell surface 
have been reported. Surprisingly, we observed that proteins derived 
from nuclear pellet and cytosol (lane 1, and 3) were labeled, indicating 
that [3 2 p] NAD might have gotten into cells by an unknown mechanism. 
As found earlier, novobiocin was a potent inhibitor of the labeling with 
the exception of the labeling of one band at approximately 36 kDa. The 
significance of this result is not known. 
The discrepancies between our findings and others can be 
explained in part by the possibility that muscle arginine-specific 
mon(ADP-ribosyl) transferase present in cultured chick myogenic cells is 
a mixed-type membrane protein with different isoforms; some are GPI-
anchored and some are transmembrane proteins. The membrane 
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fraction that we extracted from myotubes is composed of several 
cellular membranes. Therefore the enzyme and the protein substrates 
are not necessarily restricted to the cell surface. Another possibility is 
that arginine-specific ADP-ribosyltransferase present in chicken 
skeletal muscle is simply different in the properties of structure and 
substrate specificity from the enzyme found in mouse skeletal muscle. 
In summary, we identified two potential protein substrates, of 56 
k and 36 kDa, for muscle arginine-specific mono(ADP-
ribosyl) transferase in cultured myogenic cells. This finding was based 
on (1) the studies of two inhibitors, novobiocin and MIBG, on both 
endogenous and exogenous ADP-ribosylation of membrane proteins; (2) 
the inhibitory effect of DTT on the protein labelings. We also found that 
GTPyS and ATP exerted different inhibitory effects on the labeling of 
these two proteins. Immunoblot analysis showed that antibody specific 
for desmin identified the 56 kDa band. This finding strongly suggests 
that desmin might be an in vivo substrate for muscle transferase. 
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Figure 1. Endogenous (A) and exogenous (B) ADP-ribosylation of 
muscle cell membrane proteins. Membrane proteins at 
concentrations of 1 mg/ml were preincubated with 
buffer containing 20 mM isoniazid, 10 mM thymidine 
and protease inhibitors (A) or in the presence of 20 
ixg/ml of active recombinant muscle transferase (B) at 
30 oC for 5 min. ADP-ribosylation was initiated by the 
addition of 5 jiM [32p]NAD and continued for 30 min at 
30 OC. Reaction was terminated by TCA precipitation. 
Proteins were separated on 8% SDS-PAGE under 
reducing conditions followed by autoradiography. (A) 
was exposed for 24 h and (B) was exposed for 30 min. 
Lane C: in the absence of 1 mM novobiocin; lane N: in 
the presence of 1 mM novobiocin. 
(A)  (B) 
45 — 
Figure 2. Effect of different ligands on the endogenous ADP-
ribosylation of muscle cell membrane proteins. 
Different ligands added were also preincubated with 
the reaction mixture at 30 °C for 5 min and ADP-
ribosylation was carried out under conditions as 
described in "Methods". Lane 1:1 mM MIBG; lane 2: 
control without ligand addition; lane 3: 2 mM 
novobiocin; lane 4:100 |xM GTPyS; lane 5:100 nM ATP; 
lane 6:10 mM DTT. 
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Figure 3. Comparison of gel mobility of the labeled membrane 
proteins imder non-reducing (lane 1) or reducing 
conditions (lanes 2 and 3). Labeled membrane proteins 
were separated on 8% SDS-PAGE followed by 
autoradiography. Novobiocin at a concentration of 2 
mM (lane 2) was utilized as a tool to identify ADP-
ribosylated proteins. Lane C: control, in the absence of 
novobiocin; lane N: in tlie presence of novobiocin. 
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Figure 4. Identification of ADP-ribosyl protein linkage. [32p]NAD 
labeled membrane proteins catalyzed by active 
recombinant muscle transferase were incubated with 
20 ng/ml partially purified ADP-ribosylarginine 
hydrolase at 30 OC. Lane 1:0 min; lane 2: 30 min; lane 
3: 120 min; lane 4: 240 min; lane 5: 240 min control 
without hydrolase. 
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Figure 5. Immunoblot analysis of [32p]NAD labeled membrane 
proteins. The labeled membrane proteins were 
resolved on 8% SDS-PAGE imder reducing conditions 
and were transferred to Zeta-probe nylon membrane 
and immunoblotted with rabbit antibody specific for 
desmin (A) followed by autoradiography (B). Lane 1: 
endogenous ADP-ribosylation in the presence of 2 mM 
novobiocin; lane 2: endogenous ADP-ribosylation; lane 
3: ADP-ribosylation in the presence of 20 ng/ml of 
active recombinant muscle transferase. ADP-
ribosylated desmin was nm as a control (lane 4). 
(A) 
12 3 
(B) 
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Figure 6. [32p]NAD labeling of the intact embryonic chick 
primary myogenic cells in cxiltures. 96-h myotube cells 
attached to 150-mm plates were labeled with 
extracellular [32p]NAD (5 ixM) in the absence (lane 1, 3, 
and 5) or in the presence of 2 mM novobiocin (lane 2, 
4, and 6) at 37 oc for 2 h. Various cellular fractions 
(lanes 1-2: nuclear pellets; lanes 3-4: cytosolic fractions; 
lanes 5-6: membrane fractions) were extracted as 
described in "Methods". Proteins were run on a 10% 
SDS-PAGE under reducing conditions followed by 
autoradiography. Labeled membrane proteins as 
shown previously without (lane 7) or with (lane 8) 
novobiocin were used as comparison. 
1 2 3 4 5 6  7 8  
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Introduction 
The presence of arginine-specific mono(ADP-ribosyl) transferase in 
vertebrates was first demonstrated by Moss and Vaughan in 1978 (1). 
The enzyme, found in turkey erythrocytes, utiUzed p-NAD+ as an ADP-
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ribose donor, and modified arginine and its derivatives. Since then, 
similar ADP-ribosyltransferase activity was found in many different 
animal tissues, including rat liver (2), chicken liver nuclei (3) and rabbit 
skeletal muscle (4). Endogenous mono(ADP-ribosyl)ation reactions 
specific for cysteine (5) and diphthamide (6) residues have been 
identified. However, arginine-specific ADP-ribosyltransferases are the 
more extensively studied enzymes. 
Our laboratory has previously identified a membrane-associated 
arginine-specific mono(ADP-ribosyl) transferase from rabbit skeletal 
muscle (4). This muscle transferase was extracted from rabbit 
microsomes with deoxycholate and purified to homogeneity by 
successive DE-52, concanavalin A agarose, 3-aniinobenzamide agarose, 
and size-exclusion HPLC chromatographies (7). Study of this transferase 
revealed that it consists of a single subunit with a molecular mass of 
about 38 kDa. The binding of this transferase to concanavalin A agarose 
suggestes that muscle ADP-ribosyltransferase is a glycoprotein. 
Additionally, the transferase activity can be inhibited by reducing 
agents such as DTT, suggesting that disulfide bond(s) might be required 
for the biological activity of muscle transferase. Recentiy, other 
methods for the purification of muscle transferase have also been 
reported, resulting in a similar transferase activity (8, 9). 
The cDNA for rabbit skeletal muscle arginine-specific ADP-
ribosyltransferase was cloned (8). Expression of the transferase was 
shown to be tissue-specific, because its mRNA was detected primarily in 
skeletal and heart muscle (8). Based on the deduced amino acid 
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sequence, ADP-ribosyltransferase was postulated to be a 
glycosylphosphatidylinositol-anchored protein (8). This hypothesis was 
supported by the finding that treatment of intact cells or cell 
suspensions with phosphatidylinositol specific phospholypase C resulted 
in the release of transferase from the cell membrane (8, 10). No 
extensive sequence homology can be found between muscle ADP-
ribosyltransferase and any of the bacterial toxins, the ADPRT from 
Rhodospirillum rubrum, or poly(ADP-ribose)polymerase. This finding 
implied unique structural properties, and possibly different substrate 
specificity, for the muscle transferase. 
To better understand muscle arginine-specific ADP-
ribosyltransferase, its structure, catalytic properties, and substrate 
specificity, it is necessary to develop a pratical method to provide 
adequate quantities of enzyme needed for the biochemical 
characterizations. Here we describe the expression of muscle 
transferase in E. coli, and the approach we used for the refolding of 
active recombinant muscle ADP-ribosyltransferase. 
Materials and Methods 
DNA manipulation 
Rabbit skeletal muscle ADP-ribosyltransferase, subcloned into 
pBluescript plasmid and containing the full coding region, was obtained 
from Dr Moss. The transferase cDNA was amplified by PGR using 5' 
Ndel and 3' BamHI primers that were synthesized in the Nucleic Acid 
Facility at Iowa State University. Amplification was performed at a 
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melting temperature 94 oc for 7 min and 30 cycles of 94 oc for 1 
min/55 for 2 min/72 oc for 3 min, followed by extension at 72 oc for 
10 min in a volume of 100 nl. The PGR product was gel-purified using 
the glass milk method (11), and digested with Ndel and BamHI (New 
England Biolabs). The resulting fragment contained about 843 bp that 
corresponded to a truncated form of transferase (amino acids 24-304). 
The fragment was then ligated to Ndel- and BamHI-digested pETlSb 
expression vector (Novagen) with T4 DNA ligase. The nucleotide 
sequence of the coding region was confirmed by sequencing and showed 
no alteration. The expression plasmid was transformed into E. coli 
strain BL21(DE3) (Novagen). 
For use in the ThioFusion expression system (a complete 
expression kit from Invitrogen), full-length or truncated forms of 
transferase cDNA with 5' kpnl and 3' BamHI restriction sites were also 
amplified by PGR. pTrxFus expression vector was used. Digestion and 
purification of DNAs and transformation were performed according to 
the standard procedures described previously. Two E coli strains, GI724 
for expression at 30-37 oG, and GI698 for expression at less than 30 
were used. 
Expression of ADP-ribosyltransferase 
ForthepET His-Tag expression system, E coli BL21(DE3) cells 
containing the expression plasmid were first cultured in 5 ml of LB 
containing 100 ng/ml ampicillin (Amp) at 37 ©C with shaking overnight 
and then diluted 1:100 in 500 ml of LB/Amp, grown at 37 oG with 
constant shaking at 200 rpm. When an O.D.GOO of cell cultures was 
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reached, isopropyl-p-D-tiiiogalactopyranoside (IPTG) was added to the 
cell culture to a final concentration of 1 mM. The induction of 
transferase was allowed to proceed at 37 oc for Ih or 3h. The cells 
were harvested by centrifugation at 5,000 g for 5 min and the cell 
pellets were stored at -20 oc until use. 
For use in the ThioFusion expression system, GI724 or GI698 R 
coli cells with expression plasmids were grown in media containing 
casamino acid at the temperature indicated. Expression of the 
transferase fusion protein was induced by adding tryptophan. Lysis of 
cells and purification of the fusion protein by osmotic shock of whole 
cells were done according the manufacturer's instruction (Invitrogen). 
Purification of the inclusion bodies 
The cell pellets were suspended in cold deionized water and lysed 
by passage through a French pressure cell two to three times at 5000 
lb/in. pressure. The cell lysate was centrifuged at 12,000 g for 15 min 
at 4 oc. Purification of the collected pellet was carried out by sequential 
extraction steps using lysozyme, deoxycholate, DNase, RNase, and STET 
buffer (8% sucrose/50 mM Tris-HCl, pH 8.0/50 mM EDTA/5% Triton X-
100) as described (12). The final washed pellet was suspended in 50 
mM Tris-HCl, pH 8.0, and 5 mM EDTA for storage at 4 oC. 
Purification of the His-tagged ADP-ribosyltransferase 
Cell lysate derived from BL21(DE3) was prepared as described 
previously and was applied onto Ni2+-agarose. The protein was washed 
and eluted with imidazole according to manufacture's manual. 
ADP-ribosyltransferase activity assay 
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Cell lysates purified from Ni2+ ion affinity column or renatured 
proteins were assayed for ADP-ribosyltransferase activity. The reaction 
mixture contained Tris-HCl, pH 9.0, 1 mM MIBG, 1 mM NAD+, and an 
aliquot of refolded protein in a total voltmie of 300 nl. After incubation 
at 30 oc for 30 min, the reaction was stopped by adding an equal 
volume of 10% TCA and subjected to HPLC analysis as described (13). 
Protein concentration 
Protein concentrations were determined by the Bradford assay 
(14) using commercially prepared reagent from Bio-Rad. 
Results and Discussion 
We have used two different E. coli expression systems, pET-15b 
His-Tag and pTrxFus ThioFusion systems, in our attempt to express 
active muscle arginine-specific ADP-ribosyltransferase. In the pET His-
Tag expression system, a stretch of 6 consecutive histidine residues is 
placed at the N-terminus of the truncated transferase and can be 
separated from the protein, if necessary, by thrombin cleavage (Fig. 
lA). This His-Tag sequence provides a one-step rapid purification by 
binding to divalent cations (e.g. Ni2+) immobilized on the metal chelation 
resin. The expression of His-tagged muscle transferase is under the 
control of T71ac promoter and can be induced by 1 mM IPTG according 
to the manufacturer's recommendation. In the ThioFusion expression 
system, both full-length and truncated forms of muscle ADP-
ribosyltransferase are expressed as thioredoxin fusions. Due to several 
characteristics of thioredoxin, including its solubility, thermostability 
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and accumulation at adhesion zones in E. coli, fusion protein expressed 
in this system is likely to be soluble and easily purified by osmotic 
shock and heat treatment. The expression of transferase as a fusion to 
thioredoxin is driven by the bacteriophage Pl promoter and induced by 
the addition of tryptophan to growth medium (Fig. IB). 
The high-level expression of eukaryotic proteins in E coli 
sometimes results in the formation of insoluble inclusion bodies as non-
native protein aggregates. Unfortunately, the vast majority of the 
muscle transferase expressed in either system at 37 oc was present in 
inculsion bodies based on the results from transferase activity assay 
and polyacrylamide gel analysis (Fig. 2). Various growth parameters, 
e.g. the temperature for induction in either system, were tested to 
determine if active soluble muscle transferase could be obtained as 
summarized in Table 1. 
In the expression system with pTrxFus vector, the attempts to 
obtain active transferase with all conditions tried met failure (Table 1). 
No ADP-ribosyltransferase activity could be detected from either cell 
lysate or the osmotic shock fluid (data not shown). To test if 
thioredoxin interfered with ADP-ribosyltransferase activity, inclusion 
bodies of both full-length and truncated forms of transferase fusion 
proteins (Fig. 2C) were renatured as described in the section on 
refolding. We found that the truncated form of transferase fusion 
regained its activity, indicating that this small thioredoxin protein (12 
kDa) did not affect transferase activity assay or its refolding. However, 
the full-length form of transferase fusion protein still remained inactive 
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after its renaturation. In the pET His-Tag expression system, a very low 
level of ADP-ribosyltransferase activity was detected from cell lysates 
purified by Ni2+ ion affinity chromatography when cells were cultured 
at 22 oc with M9ZB media. This low expression of soluble transferase 
(<1% of baterial proteins) made the purification of muscle transferase 
difficult. It is very tempting to use inclusion bodies as the source of 
muscle transferase, because of the high yield and easy purification of 
inclusion bodies. Therefore, a truncated form of muscle ADP-
ribosyltransferase (amino acids 24-304) expressed with pET His-Tag 
vector at 37 oc (Fig. 2D) as inclusion bodies was utilized in this study. 
Because no ADP-ribosyltransferase activity was found in the 
inclusion bodies, a procedure for protein refolding was essential. 
Previously, our laboratory observed that purified muscle ADP-
ribosyltransferase was inactivated upon DTT treatment (7). This 
phenomenon suggested the likely presence of intramolecular 
disulfide(s) are required for full activity. The expressed truncated form 
of transferase contains of 6 cysteinyl residues. Thus, the redox system 
for disulfide formation was taken into account when a protein refolding 
strategy was designed. In addition, several factors e.g. denaturant, 
temperature, protein concentration, and refolding assistants, that could 
increase protein solubility were tested. 
Our initial study on the refolding of muscle ADP-
ribosyltransferase used a procedure described by Huang et. al. (15) in 
which a fully refolded truncated form of phosphorylase kinase y subunit 
was successfully obtained. Inclusion bodies of muscle ADP-
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ribosyltransferase were dissolved in 5 M guanidine-HCl/50 mM Tris-
HCl, pH 8.0/5 mM EDTA/2 mM DTT. Undissolved particulate was 
removed by centrifugation. The denatured and reduced transferase 
was diluted to 0.3 mg/ml with the same guanidine-HCl buffer. The 
renaturation of the recombinant muscle transferase was initiated by 
diluting the solution 10-fold with RE buffer (50 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 5 mM DTT, 1% CHAPS and protease inhibitors) and was 
allowed to proceed at 0 for overnight (about 12 hours). The 
precipitates were removed from the solution by centrifugation. 
Unfortunately, no detectable ADP-ribosyltransferase activity was found 
in the supernatant and the vast majority of transferase precipitated out 
during this process (Fig 3). 
A two-step renaturation procedure described by Hirose et. al. (16) 
has been successfully used in the folding of ovotransferrin that is a 78-
kDa single polypeptide containing 15 intramolecular disulfide 
bonds(16). In their first step, the reduced and denatured form of the 
protein was incubated at 0 °C in a nondenaturing buffer containing 
reduced glutathione (1 mM); in the second step, the reduced form was 
reoxidized at 22 ^C in the presence of both reduced and oxidized 
glutathione (1 mM /0.5 mM ). The rationale for two separate steps in 
the folding process is to avoid protein aggregation by decreasing the 
loss of conformational entropy upon folding of a reduced form at a 
lower temperature and by allowing the covalent process of disulfide 
formation to proceed rapidly at a higher temperature. By following the 
procedure, we were able to obtain active transferase as shown in Table 
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2. Also, we observed that when urea was used as a denaturant, the 
recovery of ADP-ribosyltransferase activity was about 10 fold higher 
than that when guanidine-HCl was used (Table 2), but the specific 
activity of the enzyme was lower. Although 10% glycerol used as a 
refolding assistant slightly impoved both protein and activity recovery 
(Table 3), the precipitation of the proteins could not be eliminated 
under those conditions, resulting in very poor recovery of refolded 
transferase. 
To avoid protein aggregation and to increase solubility during the 
folding process, we then adapted a method decribed by Albert Light 
(17) by introducing disulfide bridges between glutathione and the fully 
reduced, denatured muscle transferase as shown in Fig. 4. As the mixed 
disulfide, the thiol groups of the transferase were protected in a 
disulfide bridge and were stable and unreactive until refolding and 
disulfide interchange were both initiated. Inclusion bodies of muscle 
ADP-ribosyltransferase were solubilized in DE buffer (100 mM Tris, pH 
8.5, 1 mM EDTA, 8 M urea) containing 5 mM DTT and held at room 
temperature for 1-2 h. The concentration of the denatured, reduced 
mixture was then diluted to 0.2 mg/ml with DE buffer containing 25 
mM oxidized glutathione (GSSG) and the solution was allowed to stand 
at room temperature for overnight (about 12 h). Renaturation of 
muscle transferase was initiated by diluting the protein solution 10-50 
fold, as indicated, with RE buffer (100 mM Tris, pH 8.5,1 mM EDTA, 200 
mM NaCl, and either glucose or sucrose) containing 4 mM reduced 
glutathione (GSH), at 4 oc. All the solutions were degassed under a 
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nitrogen atmosphere before use. The renaturing mixture was 
concentrated by ultrafiltration with Amicon PM30 membrane and 
dialyzed against RE buffer for overnight. 
We successfully refolded muscle ADP-ribosyltransferase with this 
appoach and we thereafter designated this approach as "protocol-AL". 
The recovery of ADP-ribiosyltransferase activity increased rapidly 
within 30 min and reached maximum 4 hours after renaturation was 
initiated at 4 oc (Fig. 5). However, if incubation was continued, the 
recovery of activity decreased. Similar recovery of transferase activity 
was obtained with protein concentrations in the folding process up to 20 
ng/ml (Table 4). The average of yield of protein after renaturation was 
about 6% in the presence of either glucose (10-20%) or sucrose (10%) 
(Table 4). On the other hand, glycerol (10%), as compared to glucose 
and sucrose, was less effective in improving the yield of refolded 
transferase (Table 4). The gel profile of refolded muscle transferase 
was shown in Fig. 6. 
The specific activity of ADP-ribosyltransferase activity of the 
refolded protein obtained with the protocol-AL is the best thus far and 
is about 4-5 fold higher than the specific activity of enzyme prepared 
from rabbit skeletal muscle through the Con A affinity chromatography 
step. One problem not completely resolved is how to eliminate protein 
precipitation during protein folding. To this regard, a new approach 
developed by Rozema & Gellman (18) using a pair of low molecular 
weight folding assistants, a nonionic detergent POE(10)L and a 
cyclodextrin (p-CD) was applied in conjuction with protocol-AL 
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described previously to obtain active muscle ADP-ribosyltransferase 
(designated as "protocol-RG). The action of the detergent and 
cyclodextran mimics the mechanism of GroEL/S chaperone system on 
protein refolding. First, the detergent forms a complex with the 
denatured protein, thereby preventing protein self-association upon 
dilution of denaturant. Secondly, the cyclodextrin strips the amphiphile 
away from the protein, thus initiating protein folding. 
We used the specific activity of refolded recombinant muscle 
transferase obtained with the protocol-AL as 100% for comparison with 
other methods. Dilution of the mixed-disulfide transferase in the 
presence of POE(10)L followed by further dilution with p-CD and 
reduced glutathione (protocol-RG) led to the same recovery of ADP-
ribosyltransferase activity (Fig. 7, 2nd and 3rd column for 4h and 2h 
incubation, respectively) as compared to the specific activity of 
transferase obtained with protocol-AL (1st column), and to about 10% 
protein recovery. Only 26% activity was obtained (4th column) but with 
70% protein recovery if p-CD was omitted. This result indicated that 
transferase was not able to refold from the detergent-complexed state 
unless the detergent was removed away from the protein by p-CD. 
Additionally, it supports the view that POE(10)L, an amphiphile, and p-
CD, a stripping agent, mimic the action of the GroEL/S chaperone system. 
On the other hand, if the redox system (GSSG/GSH) was eliminated, even 
still in the presence of POE and p-CD, much less recovery of transferase 
activity (14.5%) was obtained (last column). 
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The arginine-specific mono(ADP-ribosyl) transferase purified from 
rabbit skeletal muscle was shown to be a glycosyl phosphatidylinositol-
anchored membrane protein (8). However, the expressed muscle 
transferase as inclusion bodies from E. coli was no longer glycosylated. 
High ADP-ribosyltrasferase activity can be recovered from its non-
glycosylated form, indicating that glycosylation of transferase is not 
essential for its full activity. Also, the hydrophobic N- and C-termini 
that were postulated to be a signal peptide and recognition site for 
glycosylation, respectively, were not involved in catalytic activity, 
because the expressed muscle transferase was a truncated form (amino 
acid 24-304). Based on the effect of DTT on the transferase activity and 
the redox system required on the transferase refolding, it strongly 
suggests that disulfide(s) are essential for its full function. Therefore, it 
is important to determine how many and which cysteinyl residues in 
transferase are involved in forming disulfide bonds. 
In conclusion, we have expressed muscle ADP-ribosyltransferase 
in E. coli in the form of inclusion bodies. An experimental approach for 
transferase refolding has been developed. It consists of several key 
steps; (1) solubilization of inclusion bodies by 8 M urea; (2) full 
reduction of transferase by DTT; (3) introduction of the mixed disulfide 
to transferase by oxidized glutathione; (4) first dilution of the mixed 
disulfide in the presence of detergent, POE(10)L; (5) further dilution 
with reduced glutathione and p-CD. The highly active recombinant 
muscle ADP-ribosyltransferase obtained with the protocol described 
here has been used in some studies like cell labeling and 
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characterization of ADP-ribosylated desmin in our laboratory. We 
believe this method should provide a precedent for further study of the 
skeletal muscle ADP-ribosyltransferase. 
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Figure 1. Diagrams illustrating the main features of (A) the His-Tagged muscle 
ADP-ribosyltransferase expression vector, pET-15, and (B) the 
thioredoxin gene fusion vector, pTrxFus, as well as the expression 
system. (A) shows the DNA sequence for the 3'-end of the lad gene, 
T71ac promoter, His-Tag leader, protease cleavage site, cloning sites, 
Eind T7 terminator. The tnmcated form of transferase (amino acid 24-
304) was cloned into the vector with 5'NdeI and 3'BamHI restriction 
sites. (B) shows that the entire thioredoxin gene is placed behind the 
bacterialphage Pl promoter in the pTrxFus followed by an 
enterokinase cleavage site. A full-length or truncated form of 
transferase was inserted in a polylinker region with 5'KpnI and 
3'BamHI sites. The regulation of the expression of transferase fusion 
is shown in this flow chart. 
A 
T7 promoler primer //693')0-1 
eg/11 T7 promoler ^ lac operator , ,bs 
AGftTCTCGATCCCGCGAAATTAMACGACTCACTATAGGGGftATrGTGAGCGGATAACftAUCCr/TCTAr.AAATAAITTTGUTAACTITAAGAAGGAGA 
Nco\ His-Jag" X/io I  SamH I  
TATACCAIGGGCAGCAGCCATCATCAICAICAlCACAnCAnCGGCCTGGTGCCGCGCGGCAGCC.MArGCTCGAGGATCCGGCrCCTAACAAAGCCCQA 
MetG lySerSorMl slU sHi si l l  sl i t  si l l  sSorSorGiyLeuVolProArgGlyScrIM rMclI.ei iGl uAspProA loAloAsnLysAlaArg 
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AAGGAAGCTGAGrTnGClGCTRCCACCGCTnARCAATAACTAr.CAIAACCCCTlGGGrXCTCIAAACaRGICnCARGGnrilTTlG 
LysG I  If AI oG I  uLeuA 1 oA I  oA 1 aThr AI oG I  uG I  nEnd 
T7 lerminalor primer #69337-1 
85 
B 
Clon« g«ne of interest 
into pTt*Fus in frame 
with the thioredoxin 
start codon. 
,TrxFus 
3.6 kb 
Transform GI724 
ceils. Isolate 
positiv&^ne and 
grow ceir^L 
Induce^rorcssion ot^ 
the fusior^rotein by 
adding t^^tophan. h pTrxFus 1 L 3.8 hB k 
Adhesion 
Zones 
Purify fusion 
protein by osmotic 
shock of whole 
cells 
treatment of cell 
Iysate|. 
Cell 
^ Tf»nscr1p»on $>-i>isa= 
.TrxFus Osmotic Shq^ H^t Treatment Fusion protein expressed 
in E. coii cell. Some 
fusions may localize at 
adhesion zones. 'Trarucnpeon is stoppcij bv rtprntiofl 
Protein of Interest 
Thioredoxin 
Enteto kinase 
Cleavage Site Optional. Cleave the 
fusion protein vWth 
enterounase to release 
the native protein. 
Figure 2. Inducible expression of rabbit skeletal muscle ADP-
ribosyltransferase at 37 oC in bacteria. 10 jil of either 
soluble (S) or insoluble (inclusion bodies) (P) fractions 
derived from £ coli ceUs expressing thioredoxin-muscle 
ADP-ribosyltransferase for 0,1, 2, 3, and 4 h was 
loaded onto a 10% SDS-PAGE gel. The full-length 
transferase fusion protein is shown in (A) and the 
truncated form is shown in (B). (C) shows the inclusion 
bodies of fuU-length (lane 1) and truncated forms (lane 
2) of transferase fusions derived from 4h-expression 
cells. Purified inclusion body of His-tagged truncated 
muscle transferase as described in "Methods" is shown 
in (D). Lane 1:1.5 h and lane 2:3.0 h expression. M: 
molecular markers. 
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Table 1. Summary of Muscle ADP-ribosyltransferase Bacterial Expression 
Vector pTrxFus pET-15b His-Tag 
Exp'ed ADPRT Full-length & Truncated Truncated form 
E coli strains GI724 GI724 GI698 GI698 BL21(DE3) B121(DE3) 
Temperature 370c 30 oC 220c 150c 370c 220c 
IPTG (1 mM) - - - - LB. LB. 
Tryptophan 
(100 ug/ml) 
I.Ba LB. I.B. LB. - -
a: Expressed His-tagged muscle transferase or thioredoxin fusion of transferase was synthesized 
as a non-native aggregates (inclusion bodies (I.B.)) in both expression systems imder conditions 
described after appropriate time periods of induction. 
Figure 3. Recombinant muscle ADP-ribosyltransferase derived from the 
supernatant (S) and precipitation (P) fractions after renaturation. 
Inclusion bodies of His-tagged truncated ADP-ribosyltransferase 
were dissolved in 5 M guanidine-HCl, 2 mM DTT buffer and 
renatured under conditions described in the text. After an 
overnight incubation at 0 oC, the solution was concentrated. The 
supernatant was separated from the precipitate by centrifugation. 
Shown is a 10% SDS-PAGE gel, stained with Coomassie blue. 
I; inclusion bodies; M: molecular markers. 

93 
Table 2. Refolding of Muscle ADP-ribosyltransfersae 
Under 2-step Conditions Using Different 
Denaturants 
Denaturant Urea Guanidine-HCl 
Sample ADPRT(SH)6 ADPRT(SH)6 
Cone, (p-g/ml) 20 20 
Mercaptan GSH/GSSG GSH/GSSG 
Protein Yield 
(%) 
0.55 2.8 
Activity^ 13.5 1.0 
Inclusion bodies were dissolved in either 8 M urea or 5 M 
guanidine-HCl in the presence of 5 mM DTT. The fully 
reduced, denatured proteins were diluted 100 fold at 0 
with RE buffer (0.1 M Tris-HCl, pH 8.2, 1 mM EDTA, and 
0.15 M NaCl) containing 1 mM GSH. After a 5-min 
incubation, the reduced proteins were incubated at 22 oc 
in the presence of GSH and GSSG (final concentrations of 1 
mM and 0.5 mM, respectively) overnight. Proteins were 
concentrated and dialyzed against RE buffer and then 
subjected to protein determination and activity assay. 
a: Activity was expressed as nmol (ADP-
ribose)MIBG/min/mg. 
Table 3. Refolding of Muscle ADP-ribosyltransferase under 2-step conditions 
Sample Cone, (mg/ml) Time (h) Activity ^ Yield (%) 
ADPRT(SH)6 20 4 16.4 2.3 
ADPRT(SH)6 20 12 24.8 1.0 
Denaturation and 2-step renaturation of transferase were performed 
according to the conditions described in Table 2 with some modifications. 
Urea was used as a denaturant. 10% glycerol was included in the RE buffer. 
a: Activity was expressed as nmol (ADP-ribose)MIBG/min/mg. 
Figure 4. The principle of muscle ADP-ribosyltransferase 
refolding. Denaturation and reduction of transferase 
were achieved by 8 M urea and 5 mM DTT. The mixed 
disulfide was introduced to muscle transferase by 
adding excess GSSG. After an overnight incubation at 
room temperature, protein folding was initiated by 
dilution with RE buffer in the presence of 4 mM GSH 
and was performed at 4 oc. 
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Figure 5. Time course of muscle ADP-ribosyltransferase 
refolding. The denatured and reduced transferase was 
incubated with 25 mM GSSG in DE buffer at room 
temperature overnight. The solution was diluted with 
RE buffer containing 4 mM GSH. After incubation at 4 
oc, protein was concentrated and dialyzed and ADP-
ribosyltransferase activity was assayed. 
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Table 4. Comparison of Refolding Parameters for the Renaturation of Muscle ADP-
ribosyltransferase 
Sample Cone. Assistant Time (h) Activity^ Yield (%) 
(fig/ml) 
1. ADPRTssG 4 20% glucose 4 1020.6 8.6 
2.ADPRTSSG 18 20% glucose 4.5 825.3 4.6 
3. ADPRTssG 18 10% glucose 4 917.2 5.3 
4. ADPRTssG 5 10% glucose 4 1145.8 5.9 
5. ADPRTssG 5 10% glucose 8 663.3 5.2 
6. ADPRTssG 2.75 10% sucrose 4 977 6.3 
7. ADPRTssG 4.7 10% sucrose 8 733 2.3 
8. ADPRTssG 2.6 30% sucrose 12 545 13.7 
9. ADPRTssG 4.7 10% glycerol 8 290 3.2 
The urea-denatured and DTT-reduced transferase was diluted with denaturing buffer 
containing 25 mM GSSG to 0.2 mg/ml. After incubation at room temperature overnight, 
the protein solution was further diluted with RE buffer (0.1 M Tris-HCl, pH 8.5,1 mM 
EDTA, 0.2 M NaCl, and assistant as indicated) for time indicated at 4 ©C. 
a: Activity was expressed as nmol(ADP-ribose)MIBG/min/mg 
Figure 6. The active recombinant muscle ADP-ribosyltransferase 
remaining in the solution after refolding process. 10 jtg 
of refolded muscle transferase was taken from 
condition 3 (lane 1) or condition 4 (lane 2) in Table 4 
and analyzed by a 10 % SDS-PAGE gel. Proteins were 
visualized with Coomassie blue. M: molecular markers. 
M 1 2 
ADPRT 
Figure 7. Comparison of the effects of different refolding 
assistants on the renaturation of muscle ADP-
ribosyltransferase. Dilution of the mixed disulfide or 
the fully reduced transferase with RE buffer in the 
presence or absence of a detergent, POE(10)L. After an 
one-hour incubation at 4 °C, protein refolding was 
allowed to proceed by further dilution with or without 
(3-CD and GSH to give a final dilution of 10-fold at 4 oC 
for 2h or 4h as indicated. RE A: 100 mM Tris-HCI, pH 
8.5/1 mM EDTA/200 mM NaCl/10% glucose. RE B: 167 
mM Tris-HCI, pH 8.5/1.7 mM EDTA/334 mM NaCl. 
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^ 60 
^ 40-
P-S-S-G + + + 
P-SH - - -
RE A - + + 
RE B + - -
POE - + + 
;8-CD - + + 
GSH + + + 
4h + + -
2h - - + 
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GENERAL SUMMARY 
ADP-ribosylation is one of the reversible post-translational 
modifications of cellular proteins. In this modification, the ADP-ribose 
moiety of p-NAD is transferred to various acceptor proteins with a 
concomitant release of nicotinamide. Poly(ADP-ribosyl)ation reactions 
are associated with eukaryotic nuclei and dependent on the presence of 
DNA breaks. The biological roles suggested for this reaction include 
DNA repair, cell differentiation, cell growth, and alteration of chromatin 
architecture. Most of these findings were obtained from experiments 
employing inhibitors of the poly(ADP-ribose)polymerase such as 3-
amino-benzamide (3-ABA). Mono(ADP-ribosyl)ation reactions are 
found in both prokaryotes and eukaryotes. Four types of ADP-
ribosylating toxins produced by bacteria, arginine-, cysteine-, 
diphthamide-, and asparagine-specific, are well characterized and their 
functions are well established. Evidence from the studies on 
prokaryotes such as R. rubrum and Rhizobium meliloti support the 
conclusion that ADP-ribosylation plays a role in the endogenous 
regulation of microbial metabolism. Several eukaryotic ADP-
ribosylating enzymes similar to the bacterial toxins have been identified 
and characterized. Among these, arginine-specific ADP-
ribosyltransferases are the most extensively studied. The physiological 
functions of these eukaryotic transferases are not yet weU defined. 
This dissertation describes a study of what role(s) arginine-
specific mono(ADP-ribosyl) transferase may have in skeletal muscle cells 
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by finding its protein substrates and by studying what ADP-ribosylation 
does to a protein's function. It also describes the study of expression 
and the refolding of muscle arginine-specific ADP-ribosyltransferase. 
Previously, we showed that an inhibitor of arginine-specific 
mono(ADP-ribosyl)transferase, MIBG, reversibly inhibits both 
differentiation and proliferation of cultured embryonic chick myoblasts. 
Additionally, we observed that arginine-specific mono(ADP-
ribosyl)transferase activity predominately is associated with the cell 
membrane and increases with cell differentiation. These findings 
suggested to us that this enzyme might play an important role in 
myogenesis and led us to screen the in vitro substrate proteins for the 
enzyme that may be important in the development of skeletal muscle. 
The muscle specific type III intermediate filament protein, 
desmin, was chosen for the in vitro substrate study because it has been 
shown to be expressed early in myogenesis. Monomeric actin appears 
to be a target for either clostridial toxins or an endogenous ADP-
ribosyltransferase found in chicken heterophils. These findings also led 
us to investigate if G-actin can be modified by skeletal muscle ADP-
ribosyltransferase. We found that muscle transferase selectively ADP-
ribosylated desmin but not G-actin (2 mol/mol vas 0.06 mol/mol). 
However, desmin was a very poor substrate for cholera toxin. Although 
cholera toxin and muscle ADP-ribosyltransferase exert similar 
enzymatic activity, they appear to have different protein substrate 
specificity. ADP-ribosylation of desmin catalyzed by muscle transferase 
resulted in the inhibition of desmin's ability to assemble. Desmin is also 
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subject to modification by phosphorylation. We demonstrated that 
phosphorylation of desmin by the catalytic subunit of PKA was 
inhibited by previous ADP-ribosylation, therefore suggesting the arginyl 
residue(s) targeted for muscle transferase are N-terminal to, and close 
to, the phosphorylation sites and are located in the head domain. More 
recentiy, the tryptic fragments derived from the modified head domain 
of desmin have been purified and are being sequenced. The sequence 
information on the ADP-ribosylation site should help us understand 
what features in the protein are important for modification by muscle 
arginine-specific ADP-ribosyltransferase. 
To further demonstrate that this regulation by ADP-ribosylation 
of desmin is possible in vivo, a [32p]NAD labeling method was used with 
cultured myoblasts as a working system because both ADP-
ribosyltransferase and ADP-ribosylhydrolase have been detected. 
Inhibitors specific for arginine-type mono(ADP-ribosyl)transferase, 
novobiocin and MIBG, were utilized as a tool to identify protein 
substrate(s) for muscle transferase. Two potential proteins with a 
molecular mass of 56 k and 36 kDa were identified in the membrane 
fractions of 96h myotube cultures. Importantly, we found that ATP 
almost completely inhibited the labeling of the 56 kDa protein, thereby 
suggesting that endogenous phosphorylation of 56 kDa protein might 
have occurred and this modification of desmin suppressed subsequent 
ADP-ribosylation. This observation, along with the results from 
immunoblot assays where an antibody specific for desmin reacted with 
the 56 kDa polypeptide, strongly suggest the possibility that the 56 kDa 
107 
protein is desmin and that it is an endogenous target for muscle ADP-
ribosyltransferase. 
Although a purification scheme for muscle transferase has been 
reported by three laboratories including ours, the time consuming 
nature of the purification process and its low yield of pure protein 
makes the biochemical study of the enzyme very difficult. Therefore, 
an expression system to generate adequate active recombinant muscle 
ADP-ribosyltransferase is needed. Both full-length and tnmcated forms 
of muscle transferase were expressed as thioredoxin fusion proteins, 
and another truncated form was expressed as a His-tagged protein in 
which a stretch of 6 histidine residues was placed N-terminal to 
transferase (amino acids 24-304). In either system, muscle ADP-
ribosyltransferase was expressed as inclusion bodies in which the 
enzyme was inactive. 
The advantages of working with inclusion bodies are that the 
protein is expressed in a very high yield and that there are less 
contaminants in the inclusion body. We therefore chose the inclusion 
body of truncated His-tagged muscle transferase as our protein source 
for further study. A protocol with a combination of the GSSG/GSH redox 
system and a pair of refolding assistants, POE( 10)L and p-cyclodextrin, 
was successfully established for the renaturation of transferase. Based 
on the effect of refolding parameters e.g. GSSG/GSH, and DTT on the 
recovery of ADP-ribosyltransferase activity, it strongly indicates that 
disulfide bonding in the muscle transferase is a critical determinant for 
enzyme activity. However, we at this point are not certain how many 
108 
pairs of disulfide are involved in maintaining the correct conformation 
of muscle transferase and which cysteinyl residues are involved in 
forming correct disulfide bridge(s). The answers to these questions 
would be very helpful for us to understand the structural or catalytic 
properties of muscle arginine-specific mono(ADP-ribosyl) transferase. 
Mutagenesis of the six cysteine residues in muscle transferase would be 
the best choice in the future. 
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